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Osteoarthritis (OA) of the knee is a degenerative disease concerning the entire knee 
joint including the cartilage and its underlying bone, the ligaments, and other soft 
tissues.1 The lifetime risk of developing symptomatic OA of the knee is almost 50%.2 
The one-year prevalence in the Netherlands of OA of the knee is almost 550.000 
patients (www.volksgezondheidenzorg.info). As for treatment options; the vast 
majority of patients will have conservative treatment that will be patient specific. For 
mid-stage OA, besides conservative treatment, surgical options could be performed 
like osteotomies. For end-stage OA a total knee replacement (TKR) is the treatment 
of choice. In the Netherlands about 28.000 TKR’s are performed annually.3 TKR is an 
effective treatment in terms of improving knee function, reducing pain and improving 
quality of life.4,5 The number of TKR’s performed worldwide, and also in the 
Netherlands, is still rising.3,6 According to the latest report of the Dutch Arthroplasty 
Registry, the LROI, in 2015 over 27.000 primary TKR’s were performed (Figure 1.1), 
which is about 26% more compared to 2010.3 
 
In 1891 the first attempt to resurface the knee joint was performed by a German 


















Figure 1.1: The amount of primary TKR registered within the LROI in the 




The subsequent versions following this prosthesis, several decades later, made of 
metal and plastic components, suffered from high rates of loosening due to the 
constraint character of these hinged types of implants. Again decades later, in the 
1970s, the development of total knee replacement had a boost due to, amongst 
others, Gunston who used an implant with two separate tibial and femoral condylar 
components. Yamamoto in Japan was the first to develop a total condylar (non-
hinged) type of design in the 1970s, which was followed, probably parallel, in the 
USA by Insall in the mid-seventies.7,9 New issues on implant design were the use of 
implants of a single-piece femoral component covering both condyles, as well as the 
use of a monoblock resurfacing tibial component. Furthermore poly-methyl-
methacrylate (PMMA) was used for fixation of the components (i.e. bone cement). In 
the 1970s different groups in Japan, the United States, United Kingdom, and 
Germany made efforts to improve TKR design. For the 1980s and the 1990s issues 
like patello-femoral joint replacement, resection of the anterior and/or posterior 
cruciate ligament, metal-backing, fixed or mobile bearing inserts and improvements 
in contact surfaces (like femoro-tibial congruency) are examples of issues surgeons 
and engineers encountered, discussed and tried to solve.7 Although changes of the 
TKR systems became smaller, compared to the early 1970s, names of the TKR’s 
changed frequently, even after minor adjustments, mainly for marketing reasons. 
Furthermore these design ameliorations, neither the ones of this millennium, 
improved final clinical outcome for patients a lot, while some of these new designs 
resulted in worse clinical outcome.10 
Success of joint replacement surgery is traditionally evaluated by survival of the 
implant or revision rates.11 Furthermore outcome measures such as range of motion 
and the presence of (anterior) knee pain were recorded. In the last decade a shift has 
occurred towards patient reported outcomes (PROM’s). Although these PROM’s are 
considered by some to give a good representation of patients’ satisfaction and 
functional gain, one should be aware that they also present only the perceived 
outcome of the pre-, intra- and postoperative complexity of TKR.12  
Literature about short- and midterm follow-up shows that not all patients are satisfied 
with the result of their TKR. Satisfaction rates after TKR are lower than rates after 
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total hip replacement (THR).13-19 Literature on long-term follow-up patient satisfaction 
is scarce.20,21 Within this thesis, patient satisfaction and quality of life at long-term 
follow-up (i.e. ten years or more after surgery) after TKR and THR is evaluated in a 
cohort from the TACTICS trial (chapter 2). This trial is a randomized controlled study 
on the effect of leukocyte depleted red blood cell transfusions versus transfusions 
packed cells containing leucocytes after TKR and THR surgery.22 Surgery was 
performed in 2000/2001 with the last clinical (i.e. PROM’s) follow-up in 2012/2013.  
An important issue to address before considering TKR surgery is the indication for 
the operation (i.e. patient selection). One of the reasons for unsatisfied patients after 
TKR could be that the decision to perform TKR was erroneous. The question of 
which patients should and which patients should not have a TKR, has been 
addressed by others as well.23,24 The indication to perform TKR and the selection of 
which patient will benefit most from surgery appears to be very important in the 
outcome of TKR.12,18,25 ,26 In chapter 3 and 4 two studies investigating the indication 
for TKR are reported. 
The overall global population in the Western part and parts of Asia is aging.27 
Patients with and without total joint replacement (TKR or THR) in the past become 
increasingly older as well. Patients of 85 years-old and older are considered the 
oldest old. Whether this oldest old patients regained their functional level and health 
status after a total joint replacement in the past is compared to oldest old without total 
joint replacement. In chapter 5 a study using the Leiden 85+ database is reported.  
The second part of this thesis focuses on more medical technical aspects that 
possibly can improve outcome of TKR. These are related to TKR design and 
materials, but also patient blood management.7,28,29 Tranexamic acid, vacuum 
drainage systems, EPO administration etcetera, have all been investigated for its use 
in reducing blood loss during and after TKR.30 Topical application of a fibrin sealant 
to reduce blood loss during and after TKR surgery has been investigated since the 
late 1990s.31 Some literature has been published in the years after, however all 
studies were performed in small patient groups and focused on transfusion frequency 
and hemoglobin loss as primary outcomes, and not on patient reported outcome 




transfusion rates have dramatically decreased during the last ten years due to 
restrictive protocols, different outcome metrics are needed, with focus on functionality 
for patients and not on the transfusion rate as such.34 Chapter 6 reports the results 
of a large randomized study using fibrin sealant focusing on functional outcome after 
TKR.  
A TKR related issue on functional outcome might be preservation or resection of the 
posterior cruciate ligament (PCL). Advocates of PCL retention pose that retaining the 
PCL is important to remain an as natural movement pattern of the knee as is possible 
in TKR.35 Furthermore, retention of the PCL might yield a better sense after TKR, due 
to mechanoreceptors for proprioception and kinesthesia within the PCL.36,37 
Sacrificing the PCL subtracts one factor that might complicate adequate ligament 
balancing, sacrificing the PCL could also prevent paradoxal femoral rollback.38,39 A 
systematic review and meta-analysis on this topic is reported in chapter 7 of this 
thesis.  
Prosthetic joint infection is a feared complication after TKR. Mild hypothermia, 
defined as a body temperature between 34.0 and 36.0 oC, during surgery is 
associated with an increased risk of infection in primary TKR and THR.40 Warming of 
the patient has become routine practice. Clean laminar airflow in operating rooms is 
considered to reduce risk of infection too. A forced-air warming blanket might disrupt 
laminar airflow and could potentially increase infection risk.41 We performed a 
randomized, non-inferiority trial, to evaluate the prevention of hypothermia in patients 
who received warming by a forced-air blanket or an active self-heating blanket. 
Results are reported in chapter 8.  
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The aims of this thesis are related to clinical outcome of Total Knee Replacement 
1. Investigating patient satisfaction and quality of life at least ten years after total 
knee or hip replacement (Chapter 2). 
2. Patient characteristics that are most probably related to the indication for TKR 
surgery by Dutch orthopedic surgeons were studied (Chapter 3) as well as 
international differences (9 countries) for the indication of TKR (chapter 4).  
a. Three patient related variables were chosen; age of the patient (old 
versus young age), severity of radiological knee osteoarthritis (OA) and 
severity of pain. 
b. International comparison was done using a large database from the 
OARSI/OMERACT initiative, with characteristics of over 1.900 patients 
with either knee or hip OA were recorded from nine different countries 
(including the Netherlands). 
3. Age as a predictor for outcome was studies in oldest-old patients who 
received total joint replacement in the past (chapter 5). 
a. To this end the Leiden 85+ database was used. A well-documented 
cohort of oldest-old patients from the Leiden area who were included 
around the start of this millennium and have annual follow-up moments. 
The second part of the thesis focuses on medical technical aspects of TKR, related 
to both the patient in general as well as to the TKR implant. 
4. Evaluation of the use of an intraoperative topical fibrin sealant on the surgical 
field  on functional outcome (extension of the leg) after TKR (Chapter 6). 
5. A meta-analysis on the functional, clinical and radiological outcome of TKR 
after retention or sacrifice of the PCL (Chapter 7). 
6. A randomized, non-inferiority trial analyzing the prevention of hypothermia in 
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Introduction. Total hip and knee replacement (THR and TKR respectively) are 
reliable and successful interventions in terms of relieving pain and improving joint 
function. Paucity exists on long-term data concerning patient satisfaction and patient 
related outcome measures (PROM’s) after THR or TKR. We studied the long-term 
patient satisfaction and PROM’s at least 10 years after THR and TKR. 
Methods. A cohort of THR and TKR patients from a randomized clinical trial was 
used. At least 10 years after primary joint replacement, patient satisfaction was 
evaluated by means of three questions:  
1. Would you still consider surgery knowing now what a THR/TKR consisted of?  
2. Would you recommend the surgery to friends or relatives?   
3. How satisfied are you at this moment with the THR/TKR? (using visual analogue 
scale)  
Furthermore the Oxford Hip/Knee scores, EQ5D scores and RAND36 scores were 
recorded. 
Results. A total of 123 patients were available for analysis. Of the THR’s 78% and of 
the TKR’s 64% would reconsider to undergo the same surgery again. Also 94% of 
the THR’s and 76% of the TKR’s would recommend the surgery to a friend or relative 
and the mean score of satisfaction was 83.1 of the THR and 80.8 of the TKR 
patients. The scores indicated that both THR and TKR patients are very satisfied at 
more than 10 years of follow-up. Furthermore comparable function and quality of life 
scores 10 years after initial surgery were found in both groups. 
Conclusion. We demonstrated that at a minimum of 10 years of follow-up both THR 
and TKR patients are very satisfied, although THR patients being slightly more 






Total hip and knee replacement (THR and TKR respectively) have both shown to be 
reliable and successful surgical procedures in terms of relieving pain, improving 
function and improving quality of life.1-3 Traditionally, clinical success of THR and 
TKR has been measured by implant survivorship, range of motion and outcome 
measures like joint stability. Next to these ‘established’ outcome variables patients’ 
perceived health after arthroplasty is important as outcome variable too, this has 
more and more been investigated this last decade.4,5 Patient satisfaction is a proxy 
for the overall success of the initial surgery. Literature shows that not all patients are 
satisfied with the results after THR or TKR.6-9 A systematic review published in 2004 
on health-related quality of life after THR and TKR was not able to identify studies 
with a follow-up period of more than 7 years.10 The majority of recent literature on 
patient reported outcome measures (PROM’s) and patient satisfaction report short-to 
mid-term outcomes.11-13 Reports on long-term satisfaction as outcome are 
scarce.14,15 
The aim of this study was to evaluate long-term patient satisfaction and patient 
reported outcome measures using validated questionnaires at least 10 years after 
THR or TKR.  
Methods 
Study population 
Patients used for this study consisted of the orthopedic subset of patients from a 
multicenter randomized clinical trial aiming to assess the difference between packed 
red blood cell transfusion with and without leukocyte depletion in THR and TKR 
patients; the TACTICS trial.16 Enrolment of the TACTICS trial took place in four 
hospitals between April 2001 and November 2002. The cohort consisted of 228 THR 
and 108 TKR patients. Ethics committee and Medical review board approval was 
obtained from the Leiden university medical center (Protocol P11.050). Written 
informed consent was obtained from all participants. 
The study was carried out on 336 THR and TKR  patients between January 2012 and 
January 2013 when patients had at least a follow-up time of 10 years. All medical 
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records in the participating hospitals were reviewed to check if patients were still alive 
and/or had complications in the course of the follow-up since inclusion (i.e. since 
index operation). Contact addresses and death or alive status were also checked 
with information from the general practitioner. All patients were contacted about the 
study and received questionnaires. Informed consent for this follow-up study was 
received from all participants too. 
Outcome measures 
Three ‘anchor questions’ with respect to outcome were posed regarding patient 
satisfaction: 
1. Knowing now what your hip/knee replacement surgery did for you, would you still 
have undergone this surgery? 
2. Would you recommend this surgery to a friend or relative if he/she had the same 
symptoms as you had before your hip/knee surgery? 
3. At this moment, how satisfied are you with the outcome of your hip/knee 
replacement? 
The first two questions had a binary (yes or no) answer; the third question used a 
visual analogue scale (VAS) ranging from 0 to 10 cm with a 100-point subdivision 
scale. Zero indicated a very dissatisfied score and ten indicated a highly satisfied 
score. 
Furthermore, function and quality of life questionnaires were recorded: the validated 
Dutch version of the modified Oxford hip and knee score (OHS and OKS 
respectively), the validated Dutch version of the EQ5D and the general health status 
RAND36.17-22 
The OHS and OKS each consist of 12 questions to describe hip or knee pain and 
physical function. Each question is answered on a five-point Likert scale, and the 
overall score is calculated by summarizing the responses to each of the 12 
questions. The total score ranges from 0-48, with a higher score indicating greater 
disability. The Oxford score uses a four band grading scale for determination of the 
joint function (0-19 may indicate severe joint problems, 20-29 may indicate moderate 




indicate satisfactory joint function).17,18,22,23 The EQ5D questionnaire has 5 items. It 
contains the domains of mobility, self-care, usual activity, pain/distress and 
depression/anxiety. It also contains one VAS-score about experienced ‘health today’ 
ranging from 0-100. The RAND-36 questionnaire has 36 items and the score ranges 
from 0-100. It focuses on physical functioning, physical role, bodily pain, general 
health, vitality, social functioning, emotional role and mentally health. It is said to take 
up to 10 minutes to complete.21,22 
Statistics 
All data were entered and analyzed using SPSS Statistics (Version 21.0. Armonk, 
NY: IBM Corp). Data for THR and TKR were analyzed separately. Univariate 
qualitative comparison was calculated using Chi-square-tests. The Student’s t-test 
was used for normally distributed quantitative parameters. Linear or logistic 
regression was applied to adjust for confounders (age and gender). A p-value of 
≤0.05 was considered to be statistically significant. 
Results 
From the 336 originally included patients, 97 (29%) patients had died, 83 (25%) 
patients were lost to follow-up (due to several reasons including missing information 
from hospital records, from GP records or simply missing), 16 (5%) patients were not 
able to and 17 (5%) were not interested in participating. Overall, 123 (37%) patients 
were able to respond to the follow-up study of which 81 THR and 42 TKR patients 
(Figure 2.1). Baseline patient characteristics at follow-up of both responders and non-
responders are presented in Table 2.1.  
Table 2.2 shows an overview of data from the completed questionnaires of THR and 
TKR patients.  
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Outcomes at follow-up 
First, the three anchor questions regarding patient satisfaction: 
1. Knowing now what your hip/knee replacement surgery did for you, would you still 
undergo this surgery?  
Of the THR patients 78% (N=63) answered yes, 12% (N=10) answered no  to this 
question, 8 participants did not answer this question. Of the TKR participants 64% 
(N=27) answered yes, 24% (N=10) answered no, 6 participants did not answer. 
More THR than TKR patients were willing to have their surgery again. 
2. Would you recommend this surgery to a friend or relative if he/she had the same 
symptoms as you had before your surgery?  
Of the THR participants 94% (N=76) answered yes, 1 participant answered no, 4 
participants did not answer this question. Of the TKR participants 76% (N=32) 
answered yes, 7% (N=3) answered no, 7 participants did not answer this 
question. More THR patients were willing to recommend their joint replacement to 
friends compared to TKR patients. 
     TACTICS start 2001
N = 336 
     TACTICS follow-up
N = 239 
contacted patients 
N = 156 
returned questionnaires 
N = 123 
deceased 
N = 97 (29%) 
lost to follow-up 
N = 83 (25%) 
not willing / not able 
to participate 




3. At this moment, how satisfied are you with your operation?  
For THR patients the mean score on the visual analogue score was 83.1 (95% CI 




Oxford hip and knee score 
Due to incomplete questionnaires, scores could not be calculated for eight patients. 
The mean OHS score was 40.0 (95% CI 38.1–42.0) and the mean OKS score was 
35.5 (95%CI 32.3–38.7) (adjusted p=0.007) (Table 2.2). A satisfactory joint function 
(i.e. 40-48 points) was obtained by 63% of the THR patients, and by 40% of the TKR 
patients. The percentage of patients, who scored 0 to 19 points, indicating severe 
joint problems, was 2.7% for THR and 10% for TKR patients. 
 
 
Table 2.1: Patient characteristics of responders and non-responders 
 
 
Responders (N = 123) Non-responders (N = 33) 
 
 
THR (N = 81)  TKR (N = 42) THR (N = 20) TKR (N = 13) 
Gender female   N(%) 62(77) 36(86) 16(80) 11(85) 
Mean age  years(SD#) 78(9.9) 78(8.6) 80(10.5) 85(8.6) 
 
 
Indication for hip/knee replacement 
Primary replacement   N(%)   59(73) 42(100) 15(75) 13(100) 
Fracture   N(%) 2(3) 0 2(10) 0 
Other   N(%) 1(1) 0 0 0 
Unknown   N(%) 19(23) 0 3(15) 0 
     
Erythrocyte transfusions    N(%) 35(43) 12(29) 7(35) 1(8) 
# SD: standard deviation. THR: Total hip replacement. TKR: Total knee replacement 
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Responders (N = 123) Non-responders (N = 33) 
 
 
THR (N = 81)  TKR (N = 42) THR (N = 20) TKR (N = 13) 
Gender female   N(%) 62(77) 36(86) 16(80) 11(85) 
Mean age  years(SD#) 78(9.9) 78(8.6) 80(10.5) 85(8.6) 
 
 
Indication for hip/knee replacement 
Primary replacement   N(%)   59(73) 42(100) 15(75) 13(100) 
Fracture   N(%) 2(3) 0 2(10) 0 
Other   N(%) 1(1) 0 0 0 
Unknown   N(%) 19(23) 0 3(15) 0 
     
Erythrocyte transfusions    N(%) 35(43) 12(29) 7(35) 1(8) 
# SD: standard deviation. THR: Total hip replacement. TKR: Total knee replacement 




Mean score for the VAS “health today” was 72.9 (95% CI 69.0–76.5) for THR and 
70.6 (95% CI 63.9–77.3) for TKR patients. The mean EQ5D score was 0.80 (95% CI 
0.76–0.85) for THR patients and 0.76 (CI 0.69–0.83) for TKR patients. 
 
Table 2.2: Completed questionnaires, Oxford hip/knee score and EQ5D 
 
 
 THR (N = 81) TKR (N = 42) 
Satisfaction     
 1. Undergo surgery again?    
 yes  78% 64% 
 no  12% 24% 
 2. Recommend surgery?    
 yes  94% 76% 
 no  1% 7% 
 3. VAS& satisfaction    
 (95% confidence interval)  83.1 (79.1 -87.2) 80.8 (74.7 - 86.9) 
 
OHS/OKS$ 
    
 0-19 (severe arthritis)  2.7% 10% 
 20-29 (moderate to severe)  4% 20% 
 30-39 (mild to moderate)  30.7% 30% 
 40-48 (satisfactory joint function)  62.7% 40% 
 95% confidence interval  40 (38.1 - 42.0) 35.5 (32.3 - 38.7) 
EQ5D     
 VAS& health today  72.9 (69.0 - 76.5) 70.6 (63.9 - 77.3) 
 Total score  0.8 (0.76 - 0.85) 0.76 (0.69 - 0.83) 
$ Oxford Hip Score / Oxford Knee Score. & Visual Analogue Scale 
 
RAND-36 
The mean scores for THR and TKR patients for the health domains are shown in 
table 2.3. There were no significant differences comparing RAND-36 results for all 

















The present study showed high quality of life scores, high patient satisfaction and 
high willingness to undergo total hip or knee replacement again at a minimum 10 of 
years after primary surgery. The willingness to have surgery again and the 
recommendation of this procedure to friends or family was higher for THR than for 
TKR patients. This difference was also found earlier by our group, and is confirmed 
by others showing less satisfied TKR patients at mid-term follow-up.24,25 Compared to 
a Dutch background population both patients who received THR and TKR have 
comparable function and quality of life scores at a minimum 10 years follow-up after 
initial surgery.10,13,15,26,27 
THR and TKR are effective from a societal perspective over the entire lifespan, with 
costs that compare favorably to those of other medical interventions.28,29 Although 
long-term implant survival in both THR and TKR has a mean survival at 10 years of 
at least 90%, these data are not well associated with perceived outcome after these 
procedures by the patient. Few studies have been published on THR and TKR 
Table 2.3: Mean RAND-36 scores per domain 
Domain # Participants THR Participants TKR 
  THA (95% CI)  TKA (95% CI) 
PCS  40.5 (37.8 – 43.1)  37.3 (33.5 – 41.1) 
MCS  53.7 (51.3 – 56.0)  54.6 (50.7 – 58.1) 
PF  37.0 (34.2 – 39.7)  35.2 (31.7 – 38.8) 
RP  44.4 (41.4 – 47.3)  42.1 ( 38.0 – 46.1) 
BP  49.6 (47.1 – 52.0)  47.7 (44.3 – 51.2) 
GH  46.0 (44.0 – 48.1)  43.7 (40.6 – 46.8) 
VT  53.0 (51.0 – 55.1)  52.7 (49.3 – 56.0) 
SF  46.8 (43.9 – 49.7)  47.2 (43.3 – 51.1) 
RE  46.7 (43.8 – 49.7)  45.7 (41.3 – 50.2) 
MH  51.5 (49.4 – 53.6)  52.7 (50.1 – 55.4) 
# PCS: physical component score, MCS: mental component score, PF: physical functioning, 
RP: role-functioning physical, BP: bodily pain, GH: general health perceptions, VT: vitality, 
SF: social role functioning, RE: emotional role functioning, MH: mental health. 
THR: Total Hip Replacement. TKR: Total Knee Replacement. CI: confidence interval 
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patients with long-term follow-up (i.e. >10 years); particularly knowledge of long-term 
patient satisfaction after such procedures is scarce. Recall bias might obscure 
negative experiences of the early postoperative period at long-term follow-up 
moments. 
Loughead et al. evaluated patient satisfaction and PROM’s in TKR patients showing 
good satisfaction and moderate functional limitations fifteen years after TKR.14 
Beverland et al. evaluated a cohort of THR and TKR patients ten years after surgery 
and found a much higher percentage ‘very happy’ patients after THR compared to 
TKR and a higher percentage of ‘never happy’ patients after TKR compared to 
THR.15 Our study not only used three questions relating to patient satisfaction it also 
has three different validated questionnaires, enabling it to provide more elaborate 
long-term results. 
If asked on the likelihood to reconsider surgery again for themselves or advice this to 
relatives/friends our study showed differences between THR (respectively 78% and 
94%) and TKR (respectively 64% and 76%) patients. In both groups almost all 
(except for four patients) said to recommend surgery to a relative or friend. Initially 
this may seem contradictory, as this means there were patients who claim to be ‘not 
satisfied’, but do recommend surgery to a friend or relative. This might very well be 
due to a lack of power and is considered a type-II error. Meeting postoperative 
patient expectations is an important determinant of the subjective postoperative 
satisfaction.30,31 
Unfortunately this study did not have detailed demographic or pre-and postoperative 
information about patient expectations. Both THR and TKR patients were highly 
satisfied given a mean score of over 80.0 for satisfaction on their joint replacement 
with THR patients being more satisfied compared to TKR patients. The latter was 
also found earlier in a different cohort of Dutch THR and TKR patients at a mean 
follow-up of 3 years. This is also substantiated by the higher Oxford hip compared to 
Oxford knee scores, thus THR patients have better pain reduction and a higher 
functionality compared to TKR patients.11,12,27 This study has several strengths. 
Patients from the study cohort were both included from academic and non-academic 




surgeons. To our knowledge it is one of the most detailed studies to date to describe 
detailed long-term satisfaction and PROM’s in THR and TKR patients using disease 
specific and generic quality of life questionnaires.  
Since the Oxford hip and knee scores did not exist when this study started, no 
preoperative data could be collected. Thus no change scores (i.e. after the 
intervention) could be calculated nor different preoperative symptom states between 
patients could be taken into account in order to have a more valid comparison 
between groups 32,33 Another limitation might be that results are based on 
responders, in long-term follow-up studies response bias is an issue since non-
responders may have different outcomes compared to responders. Responders in 
this study tended to be younger than non-responders. 
 
Conclusion 
We demonstrated that at a minimum of 10 years of follow-up both THR and TKR 
patients are on average very satisfied, THR patients being more satisfied compared 
to TKR patients. 
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Introduction. End-stage knee osteoarthritis (OA) results in total knee replacement 
(TKR) surgery. The decision to perform TKR is not well defined resulting in variation 
of indications among orthopedic surgeons. Non-operative treatment measures are 
often not extensively used. Aim of this study is to investigate factors influencing the 
decision to perform TKR by Dutch orthopedic surgeons.  
Methods. Three case vignettes, each case divided into two versions, being identical 
except for information on age (younger and older age), pain (mild and severe pain) or 
radiological OA (low and high grade) were developed. A questionnaire including 
these three case vignettes was sent to all 599 Dutch orthopedic surgeons, who were 
randomized to either one of the two versions. The orthopedic surgeons were asked if 
TKR would be the next step in treatment. Furthermore from a list of patient factors 
they were asked how strong these factors would influence the decision to perform 
TKR.  
Results. 54% of the orthopedic surgeons completed the questionnaire (N=326). 
Orthopedic surgeons indicated to perform TKR significantly more often at higher age 
(73.3% vs. 45.5%, p<0.001). In presence of mild pain orthopedic surgeons were 
slightly more reluctant to perform a TKR compared to severe pain (57.0% vs. 64.0%, 
n.s.). Mild radiological OA made surgeons more reluctant to perform TKR compared 
to severe OA (9.7% vs. 96.9%, p<0.001). 
Conclusions. Old age and severe radiological OA are variables which are considered 
to be important in the decision to perform a TKR. Pain symptoms of moderate or 






Knee osteoarthritis (OA) is a major cause of disability and functional limitations which 
affects millions of people in our aging population worldwide.1,2 A total knee 
replacement (TKR) is generally accepted to be an effective surgical treatment for 
end-stage knee OA.3-5 No succinct criteria on the decision making (i.e. patient 
selection) on TKR are available, other than “enough pain”.4 The latter not only results 
in variation among orthopedic surgeons in their decision to perform a TKR, but also 
in a potentially large percentage of patients not receiving adequate conservative (i.e. 
non-operative) treatment for knee OA.6-9 On the other hand, not all patients improve 
after TKR; a study from the Swedish arthroplasty register shows that 17-25% of the 
patients after primary TKR were not satisfied or were uncertain about the functionality 
of their TKR.10 Since patient expectations on their TKR surgery are not entirely met, 
well-timed surgery and preoperative counseling seem to be important variables to be 
addressed, even more considering the high prevalence of TKR surgery, with about 
22.000 cases in 2012 in a small country such as the Netherlands and 719.000 cases 
in the United States in 2010.11,12 Pain and the degree of radiographic OA are 
considered important variables in the decision process to perform TKR 
surgery.4,7,13,14 Preoperative pain is a strong predictor of postoperative outcome; 
patients with severe preoperative pain complaints had worse postoperative outcomes 
compared to those with less severe pain complaints.15,16 On the contrary, patients 
with mild radiological OA showed little improvement of clinical symptoms compared 
to patients with severe radiological OA.17 Most orthopedic surgeons consider a TKR 
in case of moderate to severe radiological OA but there is a well-known weak 
association between pain symptoms/functional impairment and radiological OA.14,18 
As for total hip replacement (THR), ranking determinants for their importance in the 
decision to perform surgery showed that radiological changes were of less 
importance than functional impairment, decreased range of motion and pain. Pain at 
rest, at night and/or pain during activities.19  
This emphasizes the need to explore the variables being involved in the decision 
making process to perform TKR. The aim of this study was to evaluate how these 
factors influence the opinion of Dutch orthopedic surgeons in the decision to 
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recommend TKR surgery in a given patient. We have used case vignettes to mimic 
clinical practice; this has never been done before. We hypothesized that Dutch 
orthopedic surgeons would recommend TKR to patients with high grade radiological 
OA, high levels of pain and older age. 
Materials and Methods 
In April 2012 all 599 actively practicing orthopedic surgeons in the Netherlands who 
were member of the Dutch Orthopedic Association (NOV) were contacted by e-mail 
from the NOV to participate in the study. After two and four weeks a reminder was 
sent by e-mail to those who did not respond. All orthopedic surgeons were 
randomized into two groups, both groups filled out a different version of a case 
vignette (version A or B, see Appendix). Randomization lists were generated 
randomly by a computer.  
Questionnaire  
The web-based survey used in this study was partially based on questionnaires 
previously used in surveys among orthopedic surgeons studying different 
outcomes.14,19,20 In addition, one part of the questionnaire was adapted from a study 
on geriatric oncology patients.21 This study used case vignettes with different 
versions to explore the influence of older age on oncologists’ cancer management.21 
The TKR indication questionnaire was designed and critically appraised by two 
experienced knee specialists (RN and EL). Before the final versions were distributed 
to the Dutch orthopedic surgeons a pilot-test was performed among a test-panel of 
twelve orthopedic surgeons and residents for final feedback. The software used to 
distribute the questionnaire was NetQ (NetQuestionnaires BV, Amsterdam, the 
Netherlands).  
The questionnaire was divided into three parts: part one consisted of general 
information of the respondent (gender, employment location (university medical 
center, general hospital (private group or fixed salary) or specialized private clinic), 
number of TKR performed each year (<50, 50-100 or >100) and years of 
experience).  




case vignettes of the version A and B were entirely identical except for information 
on: 1. age (old versus young age), 2. severity of pain (mild versus severe) and 3. 
radiological OA (mild versus severe radiological destruction). Case 1 version A 
described a 54-year-old patient versus version B an 86-year-old patient.  
Case 2 version A described a patient with mild pain symptoms and version B a 
patient with severe pain symptoms. Case 3 version A showed a radiograph with mild 
radiological OA and version B showed a radiograph with severe radiological OA. A 
radiograph of the knee was present in all three case vignettes (see Appendix). The 
diagnosis in all cases was primary OA with no other abnormalities in other joints of 
the lower extremities. Orthopedic surgeons were asked for each case: Is a TKR the 
next step in your treatment? “yes or no”. A short explanation in writing of the chosen 
answer was mandatory.  
Part three of the questionnaire contained factors that might affect the decision to 
perform TKR surgery. These fourteen decision modifying factors were extracted from 
current orthopedic literature including; high co-morbidity, severe osteoporosis, 
obesity, dementia, low quality of life due to the knee problems, old age, young age, 
ineffective conservative treatment, limited walking distance, dependent on activities 
of daily living (ADL) due to knee problems, moderate motivation of the patient, severe 
pain, severe radiological OA and mild radiological changes.14,19 For this part of the 
questionnaire the respondents were instructed to select an answer on a five-point 
Likert-scale: strongly against surgery, against surgery, neutral, in favor of surgery 
and strongly in favor of surgery. The factors explored in the case vignettes of part two 
were also included in this part to evaluate their importance in relation to other 
modifying factors. It was not possible to return to the previous question. 
Since no study patients were involved, official approval of an ethics board was not 
necessary.   
Statistical analysis  
For analysis of the case vignettes a Chi-squared test was used. The decision 
modifying factors of part three of the questionnaire were presented in a five-point 
Likert-scale. These factors were ranked in hierarchical order from most likely 
influencing the decision to perform TKR to most unlikely to perform TKR. ‘Strongly in 
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favor of surgery’ and ‘in favor of surgery together as well as ‘strongly against surgery’ 
and ‘against surgery’ were combined. We performed no sample size calculation since 
our sample size consisted of a fixed cohort (i.e. all actively practicing orthopedic 
surgeons member of the NOV). All analyses were performed using SPSS for 
Windows, version 20. Tests were two-tailed and p-values less than 0.05 were 
considered to be significant. 
Results 
Of the 599 questionnaires a total of 354 (59%) orthopedic surgeons responded after 
three mailings (Figure 3.1). Of the 354 responders 8 indicated not to participate in the 
questionnaire due to lack of experience in performing a TKR and 20 did not complete 
the whole questionnaire. Therefore 326 (54%) were included in the analysis. Group A 
(N=165) and B (N=161) had comparable general characteristics (Table 3.1). 
  

















599 Questionnaires sent 
Reasons no participation 
- Lack of experience with TKR: 8 
- No complete questionnaire: 20 






Table 3.1: General characteristics of the respondents, stratified by group (N=326) 
 
Characteristics  Group  
 A B Total 
 N=165 N=161 N=326 
Gender    
Male   N (%) 152 (92) 150 (93) 302 (93) 
Working environment   N (%)     
University medical center 17(10)   18 (11) 35 (11) 
Private practice in general hospital 122 (74)   114 (71)  236 (72) 
General hospital (fixed salary) 17 (10)   19 (12) 36 (11) 
Specialized knee clinic 9 (6)   10 (6) 19 (6) 
Number of knee replacements each year   N (%)    
<50      50 (30)  59 (37) 109 (34) 
50–100     91 (55) 86 (53) 177 (54) 
>100 24 (15)   16 (10) 40 (12) 
Years of experience   median (IQR) 10 (5-19)  11 (4-20)            10 (5-10) 
Values are displayed in frequency (N) and percentage (%) if not otherwise indicated. 
IQR: interquartile range.  
 
Case vignettes 
Case 1, with difference in age, showed that orthopedic surgeons were willing to 
perform a TKR more often at higher chronological age (73% vs. 46%, p<0.0001). 
Case 2, with difference in severity of pain symptoms, showed no difference on the 
decision to perform a TKR between the cases with mild and severe pain (57% vs. 
64%, n.s.). Case 3, with difference in radiological knee OA, showed that orthopedic 
surgeons were less likely to perform surgery in a patient with mild compared to 
severe radiological OA (10% vs. 97%, p<0.0001) (Table 3.2).  
If a TKR was not recommended, valgus bracing of the knee, physiotherapy and 
unicompartimental knee prostheses were frequently proposed alternatives but 
heterogeneity between each of the three case vignettes and the two versions of the 
questionnaires was seen (Table 3.3-3.5). 
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Table 3.2: Differences in TKR recommendation, stratified by group based on case vignettes 
Group  
A B  
   N=165 N=161 p-value 
Case ‘Age’  54-year-old patient (46%) 86-year-old patient (73%) <0.0001 
Case ‘Pain’  Mild pain symptoms (57%) Severe pain symptoms (64%) n.s. 
Case ‘ROA’  Mild radiological OA (10%) Severe radiological OA (97%) <0.0001 
The percentages of orthopedic surgeons who do recommend a TKR in the case vignette.                                
Case 1 described a patient a young patient (group A) and old patient (group B). Case 2 described a patient 
with mild pain symptoms (group A) and severe pain symptoms (group B). Case 3 described a patient with 
mild radiological OA (group A) and severe radiological OA (group B).   
* ROA: Radiological Osteoarthritis. n.s.: not significant. 
 
 
Decision modifying factors 
The fourteen patients’ characteristics and modifying factors were ranked in 
hierarchical order from most likely influencing the decision to perform TKR to least 
likely (Figure 3.2). The factors activities of daily life (ADL) dependency, low quality of 
life, presence of severe pain, limited walking distance, ineffective conservative 
treatment and severe radiological OA were positively associated with the decision of 
orthopedic surgeons to perform a TKR. On the other hand mild radiological OA, 
moderate motivation of the patient, high co-morbidity, dementia and young age urged 
the orthopedic surgeons less likely to perform a TKR. Presence of obesity was 
negatively associated with the decision of the orthopedic surgeons to perform a TKR, 
although one third of the respondents had a neutral opinion about obese patients 
considering a TKR. Old age and severe osteoporosis were of no clear influence in 





Table 3.3: Explanation not recommending a TKR, case ‘Age’ 
 
Case 1 ‘Age’ Group 
A (young) B (old) 
 N = 90 N = 43 
High tibial osteotomy 37 - 
Unicompartimental knee prosthesis 29 4 
Valgus bracing of the knee  17 13 
Intra-articular injection  7 11 
Expand conservative treatment 6 7 
Knee arthroscopy   6 1 
Radiographs (long leg)   6 - 
MRI   6 - 
Physiotherapy   6 5 
Patient too young 5 - 
Patient too old - 3 
Lateral heel lift 2 - 
Lack of information 1 1 
Optimize the level of painkillers 1 1 
Notes are given in multiple responses (N)   
 
Discussion 
The most important finding of the present study was that ‘older age’ and ‘moderate to 
severe radiological OA’ were important variables in the decision making process for 
TKR by Dutch orthopedic surgeons, while the ‘level of pain’ was not strongly 
associated with the indication to perform a TKR. While latter is generally considered 
an important factor to perform TKR. Furthermore we found that the factors 
‘depending on ADL’, ‘low quality of life’, ‘severe pain’, ‘limited walking distance’, 
‘ineffective conservative treatment’ and ‘severe radiological OA’ were associated with 
the decision of orthopedic surgeons to perform a TKR. 
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Table 3.4: Explanation not recommending a TKR, case ‘Pain’ 
 
Case 2 ‘Pain’ Group 
A (mild) B (severe) 
 N =  71 N = 58 
Unicompartimental knee prosthesis 19 22 
Valgus bracing of the knee 15 13 
Physiotherapy  14 6 
Intra-articular injection 11 3 
Knee arthroscopy  3 11 
High tibial osteotomy 3 7 
Lack of information 1 7 
No indication for TKR surgery 7 1 
Expand conservative treatment 4 1 
Optimize the level of painkillers 2 3 
Radiographs (stress view) - 4 
MRI 2 1 
Watchful waiting 3 - 
Lateral heel lift 1 1 
Meniscectomy 1 - 




Respondents did not consider old age as a contraindication to perform a TKR, but 
high co-morbidity negatively influenced the decision to perform TKR. Therefore, we 
assume that a relatively good health status is essential for the decision to perform a 
TKR in aged patients, which is line with the literature.20 The majority of orthopedic 
surgeons delayed recommendation of a TKR in the younger age groups (<55 years), 
probably due to a higher revision rate within this group and the unpredictable 




treatment options for this age group, like tibial osteotomy or unicompartimental knee 
prostheses.20,24-26  
Table 3.5: Explanation not recommending a TKR, case ‘Radiological OA’ 
Case 3 ‘Radiological OA’ Group 
A (mild OA) B (severe OA) 
 
N = 149 N = 5 
Discrepancy: complaints vs ROA 47 not applicable *   
Intra-articular injection 32  
MRI 24  
Knee arthroscopy 19  
Additional diagnostic testing 17  
Expand conservative treatment 17  
Physiotherapy 12  
Valgus bracing of the knee 7  
Bone scintigraphy 5  
Lack of information 5  
Radiographs (stress view) 4  
Optimize the level of painkillers 4  
X-ray (long leg) 3  
Unicompartimental knee prosthesis 2  
High tibial osteotomy 1  
Expectations too high 1  
Rheumatoid arthritis screening 1  
Weight loss 1  
Notes are given in multiple responses (N). * Only 5 respondents who did not recommend a TKR 
(3.6 % of total). 
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Current literature highlights the importance of evaluating the pain level experienced 
by patients in the preoperative period since less severe pain experienced by patients 
(i.e. non-catastrophizing pain) predicts better postoperative outcome.13,15,16 




affect the decision to recommend a TKR in the case vignettes. Based on these 
results we can conclude that OA patients presenting with knee pain in the 
Netherlands seem to undergo similar treatment, independent of their pain 
characteristics. However, severe pain is identified by 95% of the orthopedic surgeons 
as a very important variable in the decision to perform a TKR (part three of the 
study). The OA Research Society International and Outcome Measures in 
Rheumatology (OARSI-OMERACT) working group has shown that pain and function 
are weakly predictive in the surgeon’s recommendation for TKR, which underlines 
our results.7 Both results are conflicting with the importance of level of knee pain and 
function preoperatively which strongly affect the postoperative outcome of the patient 
(less severe knee OA obtain better outcome).13,15,16 
Radiological OA 
Our study showed that the degree of radiological knee OA is an important variable 
which influences the orthopedic surgeons’ decision to perform TKR, as was found by 
others as well.20 Although clear evidence exists on the discrepancy between 
presence of radiological OA and clinical symptoms, most orthopedic surgeons 
consider TKR surgery in presence of moderate to severe radiological OA.5,14,27 The 
prevalence of knee OA is increasing, caused by both increasing life span, but also a 
growing group of people suffering from overweight and therewith negative metabolic 
changes on the cartilage as well as mechanical overuse of the knee joint.28 This 
results in an increase of TKR surgery worldwide, with a predicted increase of over 
700% until 2030 in the United States.29 Not all patients with a TKR are satisfied. At 
one to five year follow-up about one fifth of patients with a TKR are not satisfied with 
their functional outcome.10,30 This stresses the importance of preoperative prediction 
models on which patients will benefit from a TKR, in order not only to increase quality 
of life of patients but also to reduce national health care costs. With the 
implementation of patient reported outcome measures (PROM’s) in national 
registries and the presence of option grids for patients based on prediction models 
for outcome, the indication for surgery, and thus the variation among orthopedic 
surgeons to recommend TKR is likely to decrease. Strengths of this study are the 
relatively large number of respondents, which gives a good reflection of the opinion 
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of the Dutch orthopedic surgeon. Second, case vignettes with each case developed 
in two versions are never used before in orthopedic questionnaire research, and are 
an effective method to analyse the symptoms (age, pain symptoms and radiological 
OA) determining the decision of an orthopedic surgeon to perform TKR. With the use 
of case vignettes a clinical setting was mimicked but this virtual setting might still be 
different from what orthopedic surgeons actually do in their own clinical practice (i.e. 
still artificial). Case vignettes do not provide all clinical information, which could affect 
the decision-making process. For that matter, the influence of conjoined factors in the 
decision making process, like young age and severe radiological OA and severe pain 
combined could not be determined. Another limitation is that an inability in the 
questionnaire existed to select no-or less experience with TKR surgery, which allows 
orthopedic surgeons to finish the questionnaire without noticing they had no or less 
experiences in knee surgery. However, the latter might also be a strong feature if it 
was a barrier for some respondents to start or complete the questionnaire. Finally, 
our results are limited to a health care system comparable to the Dutch system 
where surgeons do not receive fee-for-surgery payments or bonus plans (i.e. as an 
addition to fixed salary employment). These latter factors could also be of important 
influence in the decision to perform TKR surgery and were not investigated within this 
study.  
Further clinical research is required to clarify the indication criteria of an orthopedic 
surgeon for TKR surgery, prediction models of both the symptom state of patients in 
presence of a certain functional deficit and radiological osteoarthritis and the 
education level of the orthopedic surgeon will be important variables in such a model. 
International implementation of the case vignette questionnaire would make cross-
cultural differences in indication for TKR among surgeons visible and might define 
option grids among the different patient groups even better. 
Conclusion  
Older age and severe radiological osteoarthritis are variables resulting in the decision 
by the Dutch orthopedic surgeon to perform a TKR. Symptoms of moderate or severe 
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Appendix – Case Vignettes 
Case 1 
Medical history  
A 54 years-old (Other version: 86 years-old) woman was referred to the outpatient 
clinic with complaints of progressive knee pain, especially on the left side. No trauma 
was reported. Start-up pain and morning stiffness are present. She mentioned a VAS 
pain score of 7. There were no complaints of a locking knee and she is unable to 
walk more than 30 minutes. She wants to do many activities with her two 
grandchildren, but she is hindered because of the knee problems. 
Conservative treatment 
 Painkillers: 3 months NSAID’s with no effect.  
 Walking aids: A stick for long distance walks.  
 Intra-articular injection: Twice, with a short-term effect.  
Physical examination 
Minimal varus deformity of the left knee with effusion. Knee-flexion 100 degrees. 5 
degree of fixed flexion deformity. Collateral- and cruciate ligaments are stable. 
Patella no abnormalities.  
Standing radiograph knee    






Medical history  
A 68 year old woman is referred to the outpatient clinic and is complaining about pain 
in both knees, more on the right side. Pain is presented during activities, almost 
every day. There is no pain at rest or at night while in bed. (Other version: pain is 
constantly present including at rest and at night while in bed) Start-up pain and 
morning stiffness are present. She is incapable of bicycling and has trouble with 
walking because of the knee problems. This causes great distress in her life.    
Conservative treatment 
 Painkillers: Minimal effect of NSAID’s. 
 Walking aids: Not applicable.  
 Intra-articular injection: Few corticosteroid injections with short-term effect. 
She does not want the injections anymore.  
Physical examination 
Minimal varus deformity. Knee-flexion 110 degrees. 5 degree of fixed flexion 





Standing radiograph knee    
Is a Total Knee Replacement the next step in your treatment?  
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Medical history  
A 67 year old man with left sided knee pain is referred to the outpatient clinic. Pain at 
rest is present daily, and 2 or 3 times a week he has pain at night. Morning stiffness 
is present. Maximal walking distance is 1000 meters. It frustrates the patient that 
bicycling and working in the garden is no longer possible due to the knee problem.    
Conservative treatment 
 Painkillers: Paracetamol 4dd1 gram, if necessary diclofenac 50 mg. 
 Walking aids: A stick when walking outdoors, for the last 3 months. 
 Intra-articular injection: He is frightened of injections. 
Physical examination 
Minimal varus deformity and effusion. Knee-flexion 100 degrees. 10 degree of fixed 
flexion deformity. Collateral- and cruciate ligaments are stable. Patella-femoral 
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Within the general population the number of individuals suffering from osteoarthritis 
(OA) is growing due to ageing.1,2 OA is an important cause of disability, mortality and 
loss of function.3-5 Reported prevalences worldwide of knee OA vary from 5% up to 
30%, and of hip OA prevalences vary from 1% up to 18%.1,6 OA occurs more often in 
females than in males and prevalences rise with increasing age.6 In the Netherlands, 
the prevalence is about 850.000 cases of knee and hip OA (www.rivm.nl).  
Treatment of OA is either non-surgical or surgical, in that order. Several risks are 
related to surgical treatment, including postoperative infection, deep venous 
thrombosis and risk of significant blood loss. There are no clear guidelines for the 
recommendation of operative treatment. Indications for operative treatment, 
advocated in the literature, are the presence of radiological OA7,8 in combination with 
sufficient pain and/or disability complaints from the patient.9-11 Non-surgical treatment 
of OA consists of a broad array of different options from which many are proven 
effective.12 In the Netherlands, the Dutch Orthopedic Association (NOV) has 
established guidelines on treatment modalities for OA. The first step is the use of a 
stepped care, non-surgical approach, before surgery is considered.13,14  
In this study we compared the orthopedic surgeon’s decision to recommend a patient 
with knee or hip OA for total joint replacement in the Netherlands with this decision of 
orthopedic surgeons from several other countries in the developed world. 
Materials and methods 
Data from the OARSI-OMERACT study on pain level and functional disability in knee 
or hip OA were used.10 This study recorded indications for total joint replacement 
surgery (knee or hip) in 1.909 participants worldwide. Patients with OA of the knee or 
the hip were included and phenotyped using different characteristics and scores. 
Orthopedic surgeons were asked whether the patient was recommended for total 
knee/hip replacement (TKR/THR) or not. Inclusion took place between January 2008 
and July 2009, patients with definite radiological OA of the knee or hip attending to 
an orthopedic outpatient clinic were included. In the Netherlands one academic and 




Australia, Canada, Czech Republic, France, Germany, Sweden, United Kingdom and 
the United States. 
Demographic and clinical parameters  
In order to compare Dutch participants with participants from the other countries 
several characteristics were recorded including age, gender, and body-mass index 
(BMI) measured in kilograms per square meter. Furthermore, data on the presence 
of a joint replacement in the past were collected by self-report of the patient. 
To evaluate pain experienced by the patient a specific questionnaire was used; the 
intermittent and constant OA pain score (ICOAP).15,16 To assess clinical severity, the 
pain, stiffness and functional subscales of the Western Ontario and McMasters 
Universities OA Index (WOMAC), were used and results transformed to a 0-100 
score where higher scores correspond with worse status.17 To estimate the joint-
related quality of life, the quality of life subset of the Knee/Hip disability and OA 
Outcome Score (KOOS/HOOS) was used in the translated and validated form.18,19  
Statistical Analysis 
For normal distributed variables, means with standard deviations were calculated for 
each country / group of countries. For non-parametric variables, medians with 
interquartile ranges were calculated for each country / group of countries. Logistic 
and linear regression analysis was used, adjusting outcome scores for age, gender 
and BMI. All analyses were performed using SPSS, version 17.0. 
Results 
Patient population 
The study included 1.909 patients with OA (1.130 with knee OA and 779 with hip OA) 
who presented at the orthopedic outpatient clinic with complaints consistent with 
knee or hip OA.10 From those presenting with knee OA the mean age was 67.5 (SD 
10.4) years, mean BMI was 31.0 (SD 6.8) and 58% was female. From those patients 
presenting with hip OA the mean age was 65.0 (SD 11.4) years, mean BMI was 28.3 
(SD 5.2) and 57% was female. From the patients with knee OA 536 (47%) were 
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Results 
Patient population 
The study included 1.909 patients with OA (1.130 with knee OA and 779 with hip OA) 
who presented at the orthopedic outpatient clinic with complaints consistent with 
knee or hip OA.10 From those presenting with knee OA the mean age was 67.5 (SD 
10.4) years, mean BMI was 31.0 (SD 6.8) and 58% was female. From those patients 
presenting with hip OA the mean age was 65.0 (SD 11.4) years, mean BMI was 28.3 
(SD 5.2) and 57% was female. From the patients with knee OA 536 (47%) were 
Chapter 4  
60 
 
recommended to have TKR. From the patients with hip OA 531 (68%) were 












Characteristics of patients indicated for total joint replacement 
Table 4.1 shows characteristics of patients who were recommended for total joint 
replacement in the Netherlands and in the other countries (as a mean of the other 
countries). The mean age of Dutch patients was higher compared to the mean age in 
the other countries. BMI was slightly lower compared to the BMI abroad. 
Aforementioned is true both for TKR and THR, however differences are smaller in 
THR. THR was recommended relatively more common in the Netherlands compared 
to abroad (76% of patients with hip OA in the Netherlands versus 66% of the hip OA 
patients outside the Netherlands). TKR was recommended equally frequent in the 
Netherlands compared to abroad (45% of patients with knee OA in the Netherlands 
versus 46% of the knee OA patients outside the Netherlands).  
  
Table 4.1: Characteristics of patients who were recommended for total 
joint replacement 
                                                                               NLD                                 Other countries 
Knee (N)                                                                      (30)                                         (506) 
Age  mean (SD) 72.0 (9.8) 68.8 (9.5) 
Gender  Female N (%) 19 (63) 308 (61) 
BMI  mean (SD) 28.5 (4.4) 31.0 (6.3) 
TJR in past  yes N (%) 4 (13) 116 (23) 
Hip (N)                                                                           (50) (481) 
Age  mean (SD) 69.2 (10.4) 65.4 (10.4) 
Gender  Female N (%) 26 (52) 263 (60) 
BMI  mean (SD) 27.8 (3.8) 28.4 (4.8) 
TJR in past  yes N (%) 12 (24) 110 (23) 
NLD = the Netherlands, TKR = total knee replacement, OA = osteoarthritis, SD = standard 





Pain, function and joint-related quality of life 
For TKR recommended patients perceived pain (ICOAP score) and KOOS-PS 
scores were similar in the Netherlands and abroad. The KOOS-QoL score was 
significantly higher in knee patients in the Netherlands compared to the other 
countries’ KOOS quality of life score.  
For THR recommended patients the same results were found, including a higher 
HOOS-QoL score too. Data are displayed in table 4.2.  
Table 4.2: Pain, function and joint-related quality of life; Dutch patients vs. the other 
countries 
             NLD Other countries P-value 95%-CI of difference 
Knee (N) (30) (506)   
ICOAP total  mean (se) 50.9 (4.0) 53.4 (0.96) 0.28 -16.8 -  4.8 
     
KOOS-PS  mean (se) 60.1 (1.5)  57.9 (0.85) 0.41 -4.7  -  10.1 
KOOS-QoL  mean (se) 63.8 (1.7) 77.0 (0.76) <0.001 -20.2  - -6.6 
Hip (N) (50) (481)   
ICOAP total  mean (se) 56.2 (2.7) 58.0 (0.96) 0.93 -6.9 ; 6.3 
     
HOOS-PS  mean (se) 58.8 (2.2) 61.1 (0.69) 0.10 -8.2 ; 1.1 
HOOS-QoL  mean (se) 69.1 (1.8) 78.2 (0.77) 0.001 -14.6 ; -4.1 
P-values and 95%-confidence intervals are adjusted for: age, gender and BMI.  
NLD = the Netherlands, ICOAP = intermittent and constant OA pain score, a high score is worse pain.  
KOOS-PS / HOOS-PS = Knee/Hip and OA Outcome Score – physical short form. QoL = quality of life subscore 
KOOS / HOOS. 
Discussion 
In this short, comparative study we compared the orthopedic surgeon’s decision to 
recommend a patient with knee/hip OA for total joint replacement (i.e. TKR or THR) 
in the Netherlands with colleagues from other countries (including the United States, 
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Australia, Canada, Czech Republic, France, Germany, Sweden and the United 
Kingdom).  
Because of the relatively low numbers of patients per country this study should be 
considered as a pilot for future studies. For patients presenting with OA of the knee, 
a comparable percentage of Dutch patients were recommended for total knee 
replacement (TKR) surgery compared to the other countries. Although Dutch patients 
had severe symptoms (pain and function impairment) and somewhat older age when 
being recommended for total joint replacement compared to the other countries, the 
Dutch patients had the highest (joint-related) quality of life scores within this 
multinational comparison both in knee and hip OA patients.  
Total joint replacement is the end-stage treatment of OA, but the definition of end-
stage is not a very succinct well-defined entity. Clear guidelines when to perform total 
joint replacement surgery and what treatment modalities have to be started first in 
symptomatic patients are not (yet) used on a routine basis. In the Netherlands the 
orthopedic association (NOV) has developed a guideline recommending conservative 
treatment as a first step in the management of knee/hip OA patients. In other 
countries this is recommended as well.20-22 Although Dutch patients had severe 
symptoms (pain and function deterioration) when being indicated for total joint 
replacement, they still had the highest (joint-related) quality of life scores within this 
multi-national comparison of patients indicated for a TKR or THR. It might be argued 
that the Dutch population as a whole, has a high(er) quality of life score. For that 
matter, according to the Gallup World Poll the citizens of the Netherlands were 
considered to be the seventh happiest people in the world when the study was 
performed (http://worldhappiness.report).  
We were able to use a large, well defined, database from an international multicenter 
study in which eight developed countries are represented worldwide.10 To our 
knowledge this study is the first cohort that recorded whether a patient should have a 
total joint replacement or not, irrespective of the actual replacement of the joint took 
place. This reduces the chances on selection bias and offers the opportunity to get a 
clearer insight in the decision making process that leads to total joint replacement.  




broader insight in the recommendation for total joint replacement in these countries. 
On the other hand, larger societal differences (i.e. access to joint replacement 
surgery, social class differences, waiting lists, etc.) between these countries could 
yield even more bias, a bias that is also present in the current comparison between 
Western countries. Another major limitation is the, before mentioned, limited group 
size of patients from all participating countries. For example in the Netherlands 
patients were included from one academic and one small general hospital. This 
should be taking into account before major conclusions can be drawn.  
Endpoint was the recommendation to perform total joint replacement surgery, it was 
not recorded whether surgery took place or not, so data such as mean time between 
recommendation and surgery was not available. To learn more about the prognostic 
variables taken into account for the indication of orthopedic surgeons per country 
future studies could consist of questionnaires sent to orthopedic surgeons designed 
to find out what factor contribute to the recommendation to perform total joint surgery 
like the study reported in chapter 3 of this thesis.11 
In conclusion, TKR is indicated equally frequent in Dutch OA patients compared to 
knee OA patients from eight other developed countries.  
Dutch patients have the highest joint-related quality of life compared to other 
countries when being recommended for either TKR or THR, despite comparable pain 
and functional impairment of these joints. TKR and THR have no univocal success 
rate if patient reported outcomes (PROM’s) are used as outcome measure, this is in 
contrast to good (high) survival rates in national registries.  
An analysis into the complex decision on when to recommend TKR or THR using 
prognostic preoperative patient characteristics which might be associated to the 
different treatment modalities, would improve care of the patient with knee or hip OA. 
It would help the orthopedic surgeon when recommending TKR/THR, but might also 
help manage expectations from the patient before surgery. 
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Introduction. Total hip or knee replacement is effective in improving joint function, 
quality of life, and pain reduction. The oldest old population (i.e. 85 years and older) 
with joint replacements (TJR) is underrepresented in current literature. We compared 
health-related and functional characteristics of oldest olds with and without TJR.  
Methods. Participants aged 85 years old and older were divided into a group with and 
without TJR. Data on comorbidity, physical and joint functioning, activities of daily 
living, quality of life, and mortality rate were recorded.  
Results. A total of 38 out of 599 participants (6.3%) had received a TJR in the past. 
Participants with a TJR had slightly less comorbidities, walked slower (p=0.006), and 
complained more about hip-pain (p=0.007).  
Mortality of those with a TJR was lower during the first 8-years of follow-up (p=0.04). 
All other characteristics were comparable between groups.  
Conclusion. We conclude that subjects with a TJR performed equally well, besides 
showing a lower gait speed and a higher frequency of hip-pain. Except for the lower 







The population of oldest olds (i.e. 85 years old and older) is the fastest growing 
segment of the elderly population in the western society.1 The health status 
decreases with increasing chronological age.2 One of the major age-related diseases 
is osteoarthritis (OA), which is more common in females.3-5 In subjects between 60 
and 70 years of age, prevalences of symptomatic knee OA are reported of 
approximately 10% in males and 20% in females.4 Prevalence of knee OA is 
comparable in subjects aged 80 years and older.4,5 Symptomatic OA of the hip is 
present in approximately 5% of the 60 to 70 years old females and up to 18% in 
females of 80 years and older. In males, prevalences are slightly lower.3,4 Due to the 
demographic changes, the number of total hip replacement (THR) and total knee 
replacement (TKR) procedures steadily increases.6 Increasing age is associated with 
a higher complication and mortality rate after total joint replacement.6 However, the 
results of total joint replacement in elderly patients have been proven effective in 
terms of pain reduction, functional improvement, and cost-effectiveness and show 
similar results compared to younger patients receiving total joint replacement.7,8  
OA of the knee or the hip impairs physical activity.4 Restriction of physical activity is 
associated with numerous detrimental effects on general health status, physical 
function, and quality of life.4,9 Maintaining physical activity at older age is essential in 
order to maintain optimal health status. Treating OA, ultimately with a total joint 
replacement, influences function (i.e., flexion, extension, rotations) and quality of life 
positively.8 However, in terms of improving physical activity level, the influence of a 
total joint replacement is less clear.10 The long-term effects of receiving a total joint 
replacement have been underrepresented in the oldest old population.  
In the present study, we compared a group of oldest old subjects with and without a 
total hip or knee replacement in their history. Since surgery is performed preferably 
on healthy subjects and based on the aforementioned positive effects of total joint 
replacement, we hypothesized that the group with total joint replacement would show 
better results on physical functioning, activities of daily living, joint complaints, and 
quality of life. 
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Data was used from the Leiden 85-plus Study, a community-based prospective 
follow-up study of the inhabitants of the city of Leiden, the Netherlands. All 
participants were included at the age of 85 years. There were no exclusion criteria. 
Follow-up visits were performed annually. Enrolment of the study took place between 
1997 and 1999.11 A total of 599 persons participated in the study, 87% of all eligible 
inhabitants. The Medical Ethical Committee of the Leiden University Medical Center 
approved the study. Informed consent was obtained from all participants. 
In order to determine whether participants had received an elective TKR or THR, 
medical history concerning total joint replacement was obtained from the hospital 
charts and from information provided by general practitioners and nursing home 
physicians. 
Participant Characteristics  
Physical functioning was assessed at the participant’s home, by the following items: if 
a participant was able to stand up and walk, gait speed, a five times stand-up test, 
hand grip strength, and a physical activity score. The ability to stand up and to walk 
was recorded dichotomously. Gait speed was determined using the six meter walking 
test.12 Use of a walking aid was allowed. Gait speed was calculated using distance in 
meters and time in seconds (m/s). In the five times standup test participants were 
asked to stand up five times in a row, from sitting. Time was recorded in seconds. 
Hand grip strength, as a proxy of muscle strength, was measured with a Jamar hand 
dynamometer (Sammons Preston Inc. Bolingbrook, IL). Participants were asked to 
stand up and hold the dynamometer in the dominant hand. After one trial, 
participants were asked to squeeze three times. The maximum measurement was 
recorded in kilograms (kg).  
To calculate the physical activity score (PAS), four items from the Time Spending 
Pattern questionnaire were selected to constitute physical exercise above routine 
daily physical activity: (a) walking for fun, (b) cycling for fun, (c) exercise alone or in 




scored from 0 (no activity) to 3 (daily activity), and their sum score made up the 
Physical Activity Score (PAS).  
Activities of daily living were measured using the Groningen Activity Restriction Scale 
(GARS).14 The GARS assesses competence in abilities in nine personal basic 
activities of daily living (ADL) and nine instrumental activities of daily living (IADL). A 
summed score was calculated for basic IADL ranging from 9, indicating ability to 
perform all activities without assistance or undue effort, to 36 indicating disability. To 
assess joint complaints, participants were asked whether they experienced pain and 
stiffness of any knee or hip joint.  
Quality of life was assessed with the Cantril ladder.15 This quality of life-score uses a 
ten-point scale ranging from 0 “worst possible life” to 9 “best possible life.” 
Furthermore participants were asked to qualify their health status; results were 
dichotomized between good and poor. 
Other Characteristics of Participants  
Participants’ gender, demographics, socioeconomic status, marital status, and 
highest education were recorded. Body mass index (BMI) was calculated as weight 
in kilograms divided by height in meters squared. Chronic diseases identified from 
general practitioner and pharmacists’ records included cardiovascular disease 
(CVD), including myocardial infarction, angina pectoris, and hypertension. 
Furthermore, diabetes mellitus, obstructive pulmonary disease, Parkinson’s disease 
and arthritis (including rheumatoid arthritis and osteoarthritis) were recorded. 
Numbers of prescribed medicines were recorded from pharmacists’ records. Global 
cognitive performance was assessed with the Mini-Mental State Examination 
(MMSE).16 Furthermore the 15-item Geriatric Depression Scale (GDS-15) was used 
to measure depressive symptoms.17 This scale is developed to determine depression 
in the elderly and is filled in by the participants themselves. A score of six or more 
indicates the possible presence of depressive symptoms. Because of limited validity 
of the GDS-15 in people with moderate and severe cognitive impairment, it was 
completed only by people with MMSE scores of more than 18. 
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For continuous data means with standard deviations and for non-parametric data 
medians with interquartile ranges were calculated. Differences between the two 
groups were calculated using the t-test when data was continuous, Mann-Whitney-U 
test for nonparametric data, and chi-square test when data was dichotomous. Linear 
or logistic regression was performed to adjust for gender.  
Patient survival was analyzed using the Kaplan-Meier method. Cox regression 
analysis was used to compute a hazard ratio comparing subjects with a THR or TKR 
with subjects without a joint replacement. P-values less than 0.05 were considered to 
be significant. All statistical analyses were performed using SPSS for Windows 
(SPSS Inc., Chicago), version 17. 
Results 
From the 599 participants, 38 (6.3%) were identified with a total of 49 total joint 
replacements: 29 total hip replacements (THR) and 20 total knee replacements 
(TKR). The mean age of the subjects during their first primary joint replacement was 
78.2 (SD 4.7) years. Characteristics of participants at 85 years are shown in Table 
5.1. The prevalence of comorbidities was slightly lower in the group of participants 
with a joint replacement in the past compared to the group of participants without a 
total joint replacement. There were no statistically significant differences found 
between the two groups on any parameter except for the prevalence of arthritis. 
From the 38 participants, 28 had one total joint replacement. Five had 2 TKR’s and 
three had 2 THR’s, one had both a TKR and a THR, and one had a THR and 2 
TKR’s. 
Physical Functioning, Activities of Daily Living, Joint Complaints, and Self-Reported 
Health  
Table 5.2 shows the functional characteristics of the participants with and without 
joint replacement at age 85 years. In both groups, most of the participants were able 
to walk. Participants with a total joint replacement walked significantly slower 
compared to participants without joint replacement (p=0.006). All other tested items 





In terms of daily activities and self-reported health status, there were also no 
differences between both groups. The number of participants with a total joint 
replacement complaining about hip pain was significantly higher compared to the 
number of participants without a joint replacement (p=0.007). Within those 
participants complaining of hip pain, 11 had received at least one THR and four had 
received at least one TKR in the past. The number of participants complaining about 
knee pain differed between both groups; however, this result did not reach statistical 
significance (p=0.06). Within those complaining of knee pain, 8 participants had 
received at least one TKR and nine participants had at least one THR. Within those 
complaining about both knee and hip pain, 9 had received a TKR and 14 a THR.  
Table 5.1: Baseline characteristics of participants aged 85 years with and without total 
joint replacement in the past 
 Total joint replacement 
 Yes  (N=38) No (N=561) 
Female  N (%) 27 (71) 369 (66) 
Widowed  N(%) 23 (61) 322 (57) 
Education: primary school only  N (%) 22 (58) 331 (59) 
Living situation   
Independent  N (%) 25 (66) 304 (54) 
Sheltered  N (%) 5 (13) 155 (28) 
Institutionalized  N  (%) 8 (21) 102 (18) 
Clinical characteristics   
Body Mass Index  mean (SD) 27.6 (4.5) 27.1 (4.5) 
Mini Mental State Examination  median (IQR) 27 (25-28) 26 (22-28) 
Geriatric Depression Scale  median (IQR) 1.5 (0-2) 2 (1-3) 
Co-morbidity   
Stroke  N (%) 1 (3) 47 (8) 
CVD*  N (%) 23 (61) 380 (68) 
Diabetes Mellitus  N (%) 3 (8) 82 (15) 
Parkinson  N (%) 0 (0) 11 (2) 
COPD  N (%) 1 (3) 64 (11) 
SD = standard deviation, IQR = Interquartile Range CVD = Cardiovascular Disease. COPD = Chronic 
Obstructive Pulmonary Disease  * CVD included myocardial infarction, angina pectoris and hypertension. 
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From the participants with a THR (N=26), 42% complained about hip pain and 35% 
about knee pain. From the participants with a TKR (N=14), 29% complained about 




Table 5.2: Health and functional characteristics of participants with and without a total 
joint replacement in the past 
 Total joint replacement P-value 
 Yes (N=38) No (N=561) Crude Gender 
adjusted 
Physical functioning     
  Able to walk  N (%) 34 (90) 492 (88) 0.75 0.69 
  Gait speed  m/s, mean (SD)  0.42 (0.18) 0.53 (0.22) 0.003 0.006 
  5x stand up test  sec, median (IQR)  15.9 (12.0-18.8) 13.6 (10.8-17.8) 0.31 0.31¥ 
  Grip strength  kg, mean (SD) 21.4 (9.0) 22.7 (8.9) 0.41 0.69 
  Physical activity score  median (IQR) 3 (1 – 6) 3 (0 – 4) 0.12 0.11¥ 
GARS     
  ADL  median (IQR) 10.5 (9 – 14)  10 (9 – 15) 0.68 0.74¥ 
  IADL median (IQR) 18.5 (13 – 25)  18 (12 – 27) 0.93 0.98¥ 
Joint complaints     
  Pain hip  N (%) 15 (40) 91 (16) 0.004 0.007 
  Pain knee  N (%) 16 (42) 123 (22) 0.05 0.06 
  Stiffness hip  N (%) 8 (21) 70 (13) 0.63 0.59 
  Stiffness knee  N (%) 11 (29) 94 (17) 0.50 0.55 
Self-reported status     
  Cantril ladder  mean (SD) 7.8 (1.5) 7.5 (1.8) 0.35 0.35 
  Self-reported health “good”  N (%) 26 (88) 392 (70) 0.71 0.70 
¥ Adjustment for gender after log transformation of non-parametric variables. SD = standard deviation. IQR = 






During a total follow-up period of 12 years (median 5.8 years, interquartile range 3.1–
8.9 years), 542 (90.2%) participants died. Figure 5.1 shows the Kaplan-Meier survival 
curve of participants with and without joint replacement. During the first 10 years, 
mortality was attenuated in the group of participants with a joint replacement. When 
applying Cox regression to calculate a hazard ratio (HR) adjusted for gender, no 
significant differences in survival were found after follow-up of 12 years dependent on 
the history of joint replacement (HR of 0.86, 95%-CI [0.61,1.22], p=0.41). Cox 
regression up to eight years of follow-up showed a survival benefit of the participants 
with a joint replacement (HR of 0.60 (95%-CI [0.37, 0.98], p=0.04). 
 
Figure 5.1: mortality of participants with and without a total joint replacement in the past 
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Within the present study, characteristics of the oldest old with and without a total joint 
replacement in the past were compared. No differences in the prevalence of chronic, 
age-related diseases were found between the two groups except for the prevalence 
of arthritis. No differences in physical functioning were found except for a lower gait 
speed in the group with a total joint replacement. The group of oldest olds also 
complained more about joint pain. Furthermore, an attenuated mortality rate during 
follow-up was observed in this group. 
Gait speed is considered to be an important predictor of functional status and 
(adverse) health events.18,19 It is also related to functional activities, such as crossing 
the street.19 A recently published study confirmed our results of lower gait speed in 
subjects with a total joint replacement.19 That study showed slower gait speed in 
middle aged to elderly patients who received a THR about 2.5 years earlier.19 More 
severe joint pain is associated with lower gait speed in patients with OA.20 The group 
with total joint replacement complained more of joint pain; this could have contributed 
to the lower gait speed. It was not recorded whether the joint pain complaints came 
from the left, right, or both sides. A reason why oldest old participants with a joint 
replacement complained more about joint pain can be the presence of OA in the 
other joints. Since total joint replacement is the end-stage treatment of OA, other 
joints are likely to be affected by OA as well.21,22  
With our data, we could not perform a cost-effectiveness analysis for total joint 
replacement in the oldest old. Literature on cost-effectiveness in the general OA 
population shows that both TKR and THR are (highly) cost-effective.23,24 A smaller 
study shows cost-effective health outcomes of total knee or hip replacement in 
subjects  aged 80 years or older.25  
Reported quality of life did not differ between both groups in our cohort. This is in line 
with the results of several studies presented in a systematic review of the literature 
showing that subjects who received a TKR or THR performed similar in terms of 
health-related quality of life, as health-and age-matched controls.26 Self-reported 
health status did also not differ between both groups in our cohort. There is evidence 




middle-aged subjects.27 To our knowledge, this is the first study reporting on self-
reported health status in oldest old subjects with a total joint replacement compared 
to age-matched controls after follow-up of, on average, seven years. 
The group of participants with a total joint replacement showed a trend towards a 
healthier phenotype, especially in terms of cardiovascular and pulmonary diseases 
and attenuated mortality rate, but differences did not reach significance. Elective 
surgery such as total joint replacement is preferably performed on subjects with a low 
number of comorbidities.28,29 This could explain the difference in comorbidity and 
survival between both groups. Oldest olds with a poor physical condition might never 
have reached the age of 85 years and hence, were not included in our study. If these 
subjects were operated on despite their lesser health status, they probably died 
before inclusion in the study (i.e. before they reached the age of 85 years). 
A limitation of the study is that no detailed information about the joint replacement 
surgery, such as surgical technique and prosthesis design, data from the hospital 
admission, and adverse events (i.e. complications) was available. The presence of a 
joint replacement was recorded in the study; however, the site of replacement was 
not consequently recorded. This data was not retrieved for all participants. Another 
limitation is the lack of information about the status of OA joints (i.e. radiological 
degree of OA) in lower extremities in both groups and the extent to which the TJR 
contributes to functional level. OA status can be graded based on the radiological 
appearance.30,31 However, high-grade radiological OA is a modest indication for 
surgery since there is a poor correlation between radiological and clinical OA.5 The 
most important factor in deciding to perform a total joint replacement is enough 
pain.32 
Furthermore, the average age of participants with a joint replacement was higher 
compared to the general average age for receiving a THR being 70 to 75 years old, 
and for TKR being around 70 years old.33,34 An explanation could be that, by 
retrospectively retrieving data on joint replacement, not all implants were identified. 
Another reason can be that a group of subjects with a joint replacement deceased 
before reaching the age of 85 years. 
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reported health status in oldest old subjects with a total joint replacement compared 
to age-matched controls after follow-up of, on average, seven years. 
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number of comorbidities.28,29 This could explain the difference in comorbidity and 
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have reached the age of 85 years and hence, were not included in our study. If these 
subjects were operated on despite their lesser health status, they probably died 
before inclusion in the study (i.e. before they reached the age of 85 years). 
A limitation of the study is that no detailed information about the joint replacement 
surgery, such as surgical technique and prosthesis design, data from the hospital 
admission, and adverse events (i.e. complications) was available. The presence of a 
joint replacement was recorded in the study; however, the site of replacement was 
not consequently recorded. This data was not retrieved for all participants. Another 
limitation is the lack of information about the status of OA joints (i.e. radiological 
degree of OA) in lower extremities in both groups and the extent to which the TJR 
contributes to functional level. OA status can be graded based on the radiological 
appearance.30,31 However, high-grade radiological OA is a modest indication for 
surgery since there is a poor correlation between radiological and clinical OA.5 The 
most important factor in deciding to perform a total joint replacement is enough 
pain.32 
Furthermore, the average age of participants with a joint replacement was higher 
compared to the general average age for receiving a THR being 70 to 75 years old, 
and for TKR being around 70 years old.33,34 An explanation could be that, by 
retrospectively retrieving data on joint replacement, not all implants were identified. 
Another reason can be that a group of subjects with a joint replacement deceased 
before reaching the age of 85 years. 
Chapter 5  
78 
 
To our knowledge, this is the first study comparing an 85-year-old population who 
received a TKR or THR with their contemporaries who did not receive joint 
replacement surgery emphasizing on physical functioning, joint complaints, and 
reported health status. Current literature concerning total joint replacement in the 
oldest old patient is mostly observational, describing patient satisfaction and 
complications in cohorts of elderly patients who received a TKR or THR.6,28 Some 
studies compare the outcome after surgery with a cohort of younger patients.29,35 
Several case-control studies have been published; however, controls were matched 
based on gender, comorbidity, and surgery type rather than based on age-matched 
comparison.7,36 Another strength of our study is that the participants are part of a 
large longitudinal population-based cohort study with extensive measures for 
functioning and health with a follow-up of twelve years. 
Future research should focus more on the growing oldest old population. Based on 
our study, we observed no differences in most clinical parameters in subjects aged 
85 years with and without a joint replacement where those with a joint replacement 
walked slightly slower. Future studies should focus on gait parameters and physical 
functioning of the oldest old with and without joint replacement in order to further 
assess the impact of having a joint replacement at old age. 
Conclusion 
Oldest old participants with a joint replacement walked slower and complained more 
of joint pain compared to those without a joint replacement of the same age. 
Furthermore, the groups were comparable in terms of physical functioning, activities 
of daily living, and quality of life. Hence, having received a total knee or hip 
replacement is not associated with poorer functional level and health status except 
for a lower walking speed in those with a joint replacement, compared to subjects 
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Background. Total knee replacement (TKR) is increasingly performed in short term 
hospital stay, making same day mobilization an important issue after surgery. Little 
joint effusion, by reducing intra-articular blood loss, will enhance knee range of 
motion. The application of a topical fibrin sealant on the intraoperative bare bone and 
synovial tissue may contribute to better early full mobilization and thus improved 
functional outcomes. Since ambulation with a fully extended knee is less strenuous, 
we hypothesized that patients who received fibrin sealant would demonstrate 
improved early knee extension after six weeks compared to patients who received 
standard care.  
Methods. A multicenter randomized controlled trial in a consecutive series of 
osteoarthritis patients scheduled for TKR surgery. Participants were randomized to 
receive fibrin sealant or not before closing the knee joint capsule. Primary outcome 
was change in knee extension angle (o) at short term (2 weeks) follow-up (cExt). 
Secondary outcomes were 6 week extension angle, knee flexion angle, hemoglobin 
loss, blood transfusion rates, complication rates, the Knee Society Score, the KOOS 
and EQ5D scores.  
Results. After six-week data were available from 250 patients an interim analysis was 
performed by an independent Data Safety Monitoring Board for safety and effectivity 
assessment. This interim analysis showed that sufficient patients were included to 
detect a cExt of 10o between both groups. Inclusion was stopped but all, in the 
meantime, included patients were treated according to their randomization. A total of 
466 patients were available for analysis.  
Both groups were comparable in terms of baseline characteristics. The mean cExt 
was 0.2o (95%CI -0.5 to 0.9). No differences in secondary outcomes were found. 
Conclusions. No beneficial effects or side effects were found of a topically applied 
fibrin sealant during TKR surgery. These results discourage the clinical use of a fibrin 






The frequency of total knee replacement (TKR) for the treatment of osteoarthritis will 
increase in the coming years due to an aging population.1 In the Netherlands the 
number of TKR increased by almost 25% between 2010 and 2015 to over 26.000 
TKR’s annually (www.lroi.nl). TKR is also increasingly performed in two-day or even 
one-day surgery, necessitating the need for immediate postoperative full ambulation 
and range of motion exercises. Since the latter is restricted by intra-articular blood 
loss, ways to control this loss are important for rapid patient recovery. The 
mobilization and weight bearing is less strenuous if full extension of the knee is 
present. On a more holistic patient level, these issues have also been shown to be 
related to patient blood management.2-7 Earlier, our group demonstrated an average 
of 650-700 mL of overall (visible and non-visible) blood loss after TKR.4 Reducing this 
blood loss will most likely benefit the TKR patient. 
Theoretically, a fibrin sealant has the ability to reduce bleeding of surgically injured 
bone and synovial tissue by forming a sealing layer.6 Several randomized studies 
report on the effect of fibrin sealant in reducing blood loss (i.e. hemoglobin level) 
and/or transfusion rates after TKR.8-14 Since the introduction of modern transfusion 
trigger protocols transfusion rates have decreased tremendously and reducing 
transfusion frequency has therefore become a less relevant outcome after TKR. 
Outcome measures such as improvement of functioning and mobility are increasingly 
considered important, improving patient independence and satisfaction.  
We designed a randomized controlled clinical trial to assess the effect of a topical 
applied allogeneic single donor fibrin sealant on functional knee recovery after TKR 
surgery. We hypothesized that patients who received this topical fibrin sealant 
intraoperatively would demonstrate improved clinical favorable early knee extension 
(primary endpoint) compared to patients who received standard care. 
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transfusion frequency has therefore become a less relevant outcome after TKR. 
Outcome measures such as improvement of functioning and mobility are increasingly 
considered important, improving patient independence and satisfaction.  
We designed a randomized controlled clinical trial to assess the effect of a topical 
applied allogeneic single donor fibrin sealant on functional knee recovery after TKR 
surgery. We hypothesized that patients who received this topical fibrin sealant 
intraoperatively would demonstrate improved clinical favorable early knee extension 
(primary endpoint) compared to patients who received standard care. 
  




We conducted a single-blinded, multicenter randomized controlled trial at six 
orthopedic centers in the Netherlands. The study protocol was approved by the 
central medical ethics committee of the Leiden University Medical Center (P10.115) 
and registered at the Dutch Trial Registry (NTR2500). Local medical ethics 
committees approved the study protocol in all participating centers. A study 
independent monitor visited one of the centers to monitor legal-and protocol 
compliance. 
Patients  
Patients elected to undergo primary TKR between January 2011 and February 2013 
for the treatment of primary osteoarthritis or rheumatoid arthritis were eligible to be 
included in the study. Exclusion criteria were age under eighteen years, ASA score 
>III, any coagulation disorders, no knowledge of the Dutch language, and 
unwillingness to participate. All patients provided written and signed informed 
consent before inclusion. Patients were randomized to receive either intra-articular 
topical CryosealTM fibrin sealant (CS) or standard care without an intra-articular 
hemostat.15 A method of computer generated per-center randomization using 
permutated blocks with randomly differing block-sizes was used (ProMISeTM 
software; Leiden University Medical Center). Patients, all staff involved in data 
collection and data analysis and all authors were unaware of the treatment allocation. 
Investigational Product 
CryosealTM fibrin sealant (CS) is produced by Sanquin, the Netherlands.15 CS is 
derived from one unit of fresh frozen plasma donated by a single donor. One unit of 
single-donor quarantined plasma yields between 10-15 mL CS from which two 
syringes were transported in a sealed bag. A fibrin sealant in general is composed of 
two main components, fibrinogen and thrombin that, when mixed together at 37oC 





Protocol of Surgery  
All patients were operated on adhering to the study protocol. Type of anesthesia was 
not standardized. Tourniquet use during surgery was allowed; however, during the 
procedure the tourniquet was deflated in order to surgically coagulate injured vessels 
with electrocautery. Timing of deflation of the tourniquet was left to the orthopedic 
surgeons’ preference. All participating hospitals were free to choose their own 
preferred brand and type of TKR implant. Cementation was left to the centers 
preference. The use of a drain was an important issue when the study was 
performed. We hypothesized that the use of drainage systems may interact with the 
effect of the CS. Orthopedic centers were therefore requested to perform the 
procedure either with or without vacuum drainage for all TKR procedures at that 
center.  
For each randomized patient a cooling box was delivered to the operating room 
containing cooling elements and either CS or no CS. Before application the frozen 
CS was thawed at 40oC for at least twenty minutes. The surgeon and scrub nurse 
were informed about the content of the box only immediately before application. 
Patients assigned to the CS group were treated with a maximum of 10 mL CS 
divided over two separate syringes, one with 5 mL and one with the remaining 3-5 
mL. The use of at least 5 mL CS was mandatory. The CS was topically applied after 
placement of the implant on intra-articular tissues and bare bone surfaces. CS was 
applied with the use of a spray tip mounted on the syringe. The remaining 3-5 mL CS 
was used at the discretion of the surgeon. The knee was closed routinely. All unused 
CS and empty syringes were returned to the local blood transfusion department 
where the amount of CS applied to each patient was recorded. Standard care was 
considered TKR according to this protocol without the use of CS. 
After surgery all patients received a low molecular weight heparin thrombosis 
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Decisions regarding perioperative blood transfusion were made by the attending 
anesthesiologist and/or orthopedic surgeon, similar guidelines were in place in all 
participating hospitals. The transfusion protocol is presented in the Appendix. 
Data collection 
Data were transcribed onto Case Report Forms (CRF’s) by research nurses who 
were unaware of the randomization result. All written data were transferred from the 
CRF to the secure web-based data management system (ProMISeTM). 
Outcomes 
Primary outcome was the change in knee extension (cExt) angle (o) at short term 
follow-up (i.e. after two weeks) compared to the preoperative knee extension.  
Secondary outcomes were the six week cExt,  the knee flexion, perioperative blood 
(hemoglobin) loss, transfusion rates, postoperative pain, complications (superficial 
and deep infection, hematoma, and systemic complications), and total duration of 
hospital stay. Furthermore the Knee Society score and validated patient reported 
outcome scores; the Dutch versions of the Knee Injury and Osteoarthritis Outcome 
Score (KOOS)16 and the EQ5-D17 were recorded. Outcomes were recorded at 
baseline and 2- 6- and 52 weeks after surgery. 
Sample size 
A sample size calculation was performed for our primary outcome which is cExt two 
weeks after surgery. A difference between study arms of 10o was expected and was 
also considered clinically relevant. Because of scarcity of data to base our 
calculations on, based on the date from a trial registered on clinicaltrials.gov 
(NCT00492219) a standard deviation of 35 degrees was assumed. The sample size 
needed to detect a difference of 10o with a t-test assuming equal standard deviation 
in both groups of 35 is 259 per group (using the O’Brien-Fleming rule for one interim 
analysis. Because of the scarcity of data during development of the study protocol a 
re-estimation of the sample size was specified in the protocol after the first 250 





According to the protocol a single interim analysis was conducted by an independent 
Data Safety Monitoring Board (DSMB) when 2-week follow-up data were available 
from 250 patients (because of overshoot this turned out to be N=262 included in 
interim analysis). The interim analysis was intended as both a safety assessment and 
superiority analysis as well as used to re-estimate the sample size. 
Ultimately an interim analysis of the first 262 evaluable patients was performed. All 
(serious) adverse events were recorded. The DSMB judged whether an adverse 
event was possibly related to treatment with CS. The DSMB was blinded to group 
allocation when assessing the data. The standard deviation of cExt between baseline 
and 2 weeks was 7.7 according to the interim analysis. It was concluded that in the 
study protocol the standard deviation of the primary outcome was over-estimated. 
According to this new sample size calculation there was already enough power to 
stop inclusion. However, because the protocol stated at least 400 patients were to be 
included, it was decided to continue until this amount was reached. Ultimately over 
400 patients were included because of  overshoot of inclusion.  
Statistics 
Descriptive statistics are reported as number and percentage for categorical 
variables. Normally distributed continuous variables are reported as mean and 
standard deviation and non-normally distributed continuous variables as median and 
inter-quartile range.  
Primary outcome 
A repeated measure linear mixed model was used to assess the difference in cExt 
between patients randomized for Standard Care and CryoSeal fibrin sealant, 
adjusting for pre-operative knee extension angles (crude model). The model was 
adjusted for any misbalance in baseline characteristics between the randomized 
groups (Model 1). To investigate whether the CS effect was modified by the use of a 
drain, drain use and the interaction between drain use and CS versus standard care 
was added to the model (Model 2).  
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For the secondary outcome change in knee extension after 6 week and for change in 
knee flexion, the same repeated measurement analysis of covariance was performed 
as for the primary outcome adjusting for preoperative knee flexion. EQ5D and VAS 
were compared by mean and interquartile range for both randomization groups pre-
operatively and after six weeks of follow-up.  
 
Analyses were carried out according to the intension-to-treat (ITT) principle.  
Difference in estimated mean differences between CS and Standard Care arms and 
their 95% confidence intervals were computed with the Standard care arm as a 
reference group. Statistical analysis was performed with computer software (SPSS 
20.0 for Windows, SPSS Chicago, IL.). Statistical tests were two sided, a p-value of 
<0.05 was considered statistical significant.  
 
Results 
A total of 498 patients were randomized between January 2011 and February 2013. 
From these patients a total of twenty-four (twelve patients in each study arm) 
ultimately did not undergo TKR surgery or withdrew their informed consent (IC). A 
further four eligible patients (3 in CS arm and 1 in control arm) gave IC twice and 
were included by randomization for a second TKR at least three months later on the 
contra-lateral side. Eight patients who underwent TKR were excluded for analysis 
due to the missing cExt data pre- or postoperatively.  
A total of 466 patients were available for analysis; 232 in the CS arm and 234 in the 
control arm (Figure 6.1). Due to random logistical reasons with the different clinics no 
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Table 6.1: Characteristics of participants 
                                                                                           Standard Care                            CryoSeal 
Baseline variables 
Number of patients 234 232 
Females  N (%)   152 (65)   148 (64) 
Age  years (SD) 68 (9)  68  (10) 
Body mass index  kg/m2 (SD)   29 (5) 29 (5) 
ASA score  N (%)     
      I  44 (19) 32 (14)  
      II or III  182 (78)  185 (80) 
Associated co-morbidity  N (%)   
     Diabetes Mellitus 47 (20)   31 (13) 
Type of OA  N (%)      
    Primary OA 215 (92) 203 (88) 
Preoperative variables 
Hemoglobin  g/dL mean (SD) 13.8 (1.3) 13.7 (1.4) 
Pain score  0-10 median (IQR) 7 (5 to 8) 7 (5 to 8) 
Knee extension angle  0 median (IQR) -2.5 (0 to -5) -5.0 (0 to -10) 
Preoperative extension deficit ≤150  N (%) 26 (11) 37 (16) 
Flexion angle  0 median (IQR) 110 (100 to 120) 110 (100 to 120) 
Perioperative variables 
CS fibrin sealant use  N (%)  1 (0.4) 211 (92) 
Surgical time  minutes (IQR) 75 (60 to 100) 76 (62 to 97) 
Length of hospital stay  days (IQR) 4 (3-4) 4 (3-4) 
Drain system used  N (%) 87 (38) 79 (34) 
Drain production  mL (IQR)  477 (312 to 730) 550 (325 to 760) 
RBC transfusions  N (%) 11 (4.7) 8 (3.4) 
Cemented implant  N (%) 200 (85) 197 (85) 
N, number; SD, standard deviation; IQR, interquartile range;  ASA, American Society of Anesthesiologists score; 







Table 6.1 shows pre-and perioperative characteristics of randomized patients. The 
only difference at baseline was a higher incidence of diabetes in the control arm.  
Primary outcome 
The results of the intention-to-treat (ITT)-analysis mean change in postoperative 
knee extension (cExt) for patients randomized for standard care and CS after 2 
weeks are shown in table 6.2. The overall mean cExt at short term follow-up was 
comparable between CS (crude model: CS 2.0o (95%CI 1.6o to 2.5o) and standard 
care 1.8o (95% CI 1.4o to 2.3o); mean difference of 0.2o (95%CI -0.5 to 0.9). Both 
arms were comparable after adjusting for diabetes (model 1). Also there was no  
interaction between drain usage and CS (model 2). 
Table 6.2: Primary outcome, cExt, two weeks after TKR 
                                                                                      Mean cExt (95%-CI) 
 
Model 1   
(adjusted for DM) Standard care 1.2 (0.5 to 1.8) 
 CS fibrin 1.0 (0.3 to 1.6) 
   
Model 2  
(adjusted for drain) 
  
   
Drain + Standard care 0.9 (0.1 to 1.7) 
 CS fibrin 1.7 (0.7 to 2.6) 
Drain -  Standard care 1.3 (0.6 to 2.1) 
 CS fibrin 0.6 (-0.2 to 1.3) 
   
cExt: mean change in extension, TKR: total knee replacement, 95%-CI: 95% 
confidence interval, DM: diabetes mellitus, CS: CryoSeal 
 
Secondary outcomes 
Both study arms showed equal improvement in cExt at 6 weeks compared to 2 
weeks (Appendix table A). There was no difference in change in knee flexion in CS 
patients compared to standard care. Also there was no difference in length of 
hospital stay between both groups (median 4 days, IQR 3-4). The Knee Society 
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scores significantly improved after surgery, and comparing these scores between the 
groups did not yield a difference (Appendix Table B). The EQ5D VAS was also 
similar for both treatment groups. All subscales of the KOOS improved after the 
surgery, there were no differences between both groups (Appendix Figure A) 
Complications  
Postoperative (serious) adverse events were scored up to one year postoperatively. 
Table 6.3 shows the complications per treatment arm. Complication rates were low 
and similar for the two intervention arms. 
Table 6.3: Complications 
 Standard care CS fibrin 
Wound infection 5 (2.1) 8 (3.4) 
Deep infection 1 (0.4) 3 (1.3) 
Manipulation knee (OR) 3 (1.3) 0 (0) 
Manipulation knee (ward) 3 (1.3) 1 (0.4) 
Knee hematoma 1 (0.4) 4 (1.7) 
Pneumonia 1 (0.4) 2 (0.9) 
Urinary tract infection 4 (1.7) 3 (1.3) 
Admission ICU 1 (0.4) 2 (0.9) 
Cardial events 10 (4.2) 6 (2.6) 
Respiratory events 4 (1.7) 1 (0.4) 
Neurologic events 0 (0) 3 (1.3) 
Complications are reported as number (between brackets is percentage 
of total of treatment group)  
 
Discussion 
Topical application of a fibrin sealant (CS) did not improve postoperative knee 
extension at short-term (2 weeks) follow-up after TKR compared to standard care. 
For this study a difference in extension angle of 10o improvement or more was 
defined as clinically relevant.18 However, this pre-defined clinical relevant knee 




deficit was only 5o (IQR 0o to 10o). Nonetheless the study results also accentuate that 
despite extensive surgery to a knee (TKR) which creates large bleeding surfaces, the 
intra-articular blood loss does not seem to interfere with short-term range of motion.   
Two meta-analyses studied the effect of fibrin sealant in TKR surgery, both showing 
a reduction of postoperative blood loss in the fibrin sealant group with a subsequent 
decrease in postoperative drainage and red blood cell transfusion rates.2,14 Both 
found no difference in complication rate between fibrin sealant and control groups. In 
contrast to our study Wang et al. showed in meta-analysis a significantly improved 
overall mean range of motion (i.e. flexion to extension) of 16o in patients (N=144) 
treated with a fibrin sealant compared to those who were not treated with fibrin.14 
However this pooled mean was based on a small number of patients from only 2 
studies with significant heterogeneity.  
Preventing blood loss perioperatively may include numerous strategies. 
Intraoperative strategies could include administration of pharmacological agents, i.e. 
tranexamic acid application, but also topical hemostats such as fibrin sealants.3,6  
Since generic measures for patient blood management have reduced blood 
transfusion considerably, focus within blood management has also shifted towards 
improvement of quality of life and functionality of the patient.4 Therefore we 
addressed the surgical bleeding area, since this has impact on early ambulation as 
well as knee mobility of the surgically treated joint. 
An analysis of functional outcome as primary outcome (i.e. knee extension) has not 
been investigated in the context of patient blood management. Knee extension deficit 
was used as a primary outcome since ambulating with a flexed knee is more 
strenuous for the patient with subsequent more energy consumption in the 
postoperative period.  A recent small study (N=48 knees) described the effect of fibrin 
sealant on blood loss and, for the first time in the literature, on early functional 
recovery defined by knee swelling, pain, range of motion and strength of knee 
extension.12 Twenty-four patients receiving bilateral simultaneous TKR were 
analyzed with neither any benefit of fibrin sealant in this small patient sample. 
Another recent study evaluated the effect of topical application of fibrinogen in TKR in 
200 patients, showing no difference in terms of blood loss or transfusion frequency.19 
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Two meta-analyses studied the effect of fibrin sealant in TKR surgery, both showing 
a reduction of postoperative blood loss in the fibrin sealant group with a subsequent 
decrease in postoperative drainage and red blood cell transfusion rates.2,14 Both 
found no difference in complication rate between fibrin sealant and control groups. In 
contrast to our study Wang et al. showed in meta-analysis a significantly improved 
overall mean range of motion (i.e. flexion to extension) of 16o in patients (N=144) 
treated with a fibrin sealant compared to those who were not treated with fibrin.14 
However this pooled mean was based on a small number of patients from only 2 
studies with significant heterogeneity.  
Preventing blood loss perioperatively may include numerous strategies. 
Intraoperative strategies could include administration of pharmacological agents, i.e. 
tranexamic acid application, but also topical hemostats such as fibrin sealants.3,6  
Since generic measures for patient blood management have reduced blood 
transfusion considerably, focus within blood management has also shifted towards 
improvement of quality of life and functionality of the patient.4 Therefore we 
addressed the surgical bleeding area, since this has impact on early ambulation as 
well as knee mobility of the surgically treated joint. 
An analysis of functional outcome as primary outcome (i.e. knee extension) has not 
been investigated in the context of patient blood management. Knee extension deficit 
was used as a primary outcome since ambulating with a flexed knee is more 
strenuous for the patient with subsequent more energy consumption in the 
postoperative period.  A recent small study (N=48 knees) described the effect of fibrin 
sealant on blood loss and, for the first time in the literature, on early functional 
recovery defined by knee swelling, pain, range of motion and strength of knee 
extension.12 Twenty-four patients receiving bilateral simultaneous TKR were 
analyzed with neither any benefit of fibrin sealant in this small patient sample. 
Another recent study evaluated the effect of topical application of fibrinogen in TKR in 
200 patients, showing no difference in terms of blood loss or transfusion frequency.19 
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Small studies have been performed assessing the optimal dosage of fibrin sealant in 
TKR; 2 mL is considered too little while 5 mL was considered enough compared to 
10 mL in a TKR study.20,21  
We studied a large sample of TKR patients in a prospective randomized controlled 
trial, with the passive extension deficit of the knee as functional endpoint. This is the 
first RCT with sufficient power to measure a putative effect of fibrin sealant on 
functional recovery of the knee. We advocate, since patient blood management is 
well implemented in current clinical practice in the Netherlands, that knee extension 
is a clinically more relevant outcome measure than transfusion rates and hemoglobin 
loss. Transfusion rates in the Netherlands were already low, being 11% in a total of 
2.500 TKR and total hip replacement patients study on patient blood management in 
2010.4,22 These have dropped even further to 4% in the current TKR study.  
A limitation of our study is that we used standard care as control and also standard 
care with respect to the center’s preference to the use of a postoperative drain. It was 
considered that interference of the clinical practice during the study period (use or 
non-use of drain system) would cause a larger bias than just accept center wide use 
or no use of a drain. The study protocol allowed several factors to the preference per 
center (i.e. not individual preference). Another limitation is that measurements of 
knee angle were performed using goniometry, which is considered to be imprecise. 
However, due to the large number of patients included, the randomized design and 
blinded analysis of the study data, even the small mean change in postoperative 
extension in outcomes could very well be clinically interpretable even more since 
inter-observer variability of range of motion measurements using a goniometer show 
good reliability in literature.23 
Conclusion 
This study demonstrated no beneficial effects or side effects of CS fibrin sealant on 
the functional postoperative recovery after total knee replacement surgery. There 
was no difference in change of knee extension after TKR between patient treated 
with topical fibrin sealant or with standard care. There was also no difference 
between these groups in change of other postoperative outcomes. These results 
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Appendix Table A: Mean change in knee extension compared to the preoperative extension 
after 2 and 6 weeks in both drain and non-drain users 
Model   Mean change extension angle (95% CI) 
   Overall 
(up to 6 weeks) 
at 2 weeks at 6 weeks 
Crude model Standard Care  2.0 (1.6 to 2.5)   
 CS  1.8 (1.4 to 2.3)   
Model 1   Standard Care  1.7 (1.2 to 2.3) 1.2 (0.5 to 1.8) 2.3 (1.7 to 2.8) 
(adjusted for diabetes) CS  1.5 (0.9 to 2.1) 1.0 (0.3 to 1.6) 2.1 (1.4 to 2.6) 
Model 2 
(usage of drain)  
     
Drain + Standard Care  1.5 (0.7 to 2.3) 0.9 (0.1 to 1.7) 2.0 (1.2 to 2.8) 
 CS  2.2 (1.3 to 3.1) 1.7 (0.7 to 2.6) 2.8 (1.9 to 3.6) 
Drain - Standard Care  1.9 (1.2 to 2.6) 1.3 (0.6 to 2.1) 2.4 (1.7 to 3.1) 
 CS  1.1 (0.5 to 1.8) 0.6 (-0.2 to 1.3) 1.7 (1.0 to 2.4) 
Data shown as mean cExt. angle (95%CI). Overall (up to 6 wk) and 2 and 6 week change in knee extension angle 
are shown as crude, adjusted (Model 1) and interaction between the drain and randomized groups (Model 2).  
 
 
Appendix Table B: Knee Society Scores: Knee and Functional score 
Knee Society Score Pre 6 weeks 52 weeks 
 Standard CS Standard CS Standard CS 
Knee Score 51 (17) 51 (17) 80 (17) 78 (17) 92 (10) 90 (14) 
Functional Score 47 (21) 46 (19) 59 (23) 56 (22) 77 (23) 76 (25) 
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Appendix Figure A: KOOS subscales preoperative and throughout follow-up 
 





Appendix Transfusion protocol 
 
Patients younger than 60 years  
Within 4 hours after surgery   More than 4 hours after surgery  
Hb ≥ 4.0 mmol / l = 0 packed cell  Hb ≥ 4.0 mmol / l = 0 packed cell  
3.0 - < 4.0 = 1 packed cell   3.5 - < 4.0 = 1 packed cell  
< 3.0 = 2 packed cells    < 3.5 = 2 packed cells  
 
Patients older than 60 years  
Within 4 hours after surgery   More than 4 hours after surgery  
Hb ≥ 4.5 mmol / l = 0 packed cell  Hb ≥ 5.0 mmol / l = 0 packed cell  
4.0 - < 4.5 = 1 packed cell   4.5 - < 5.0 = 1 packed cell  
 < 4.0 = 2 packed cells    < 4.5 = 2 packed cells  
 
Patients with increased risk (because of co-morbidity)  
Within 4 hours after surgery   More than 4 hours after surgery  
Hb ≥ 5.5 mmol / l = 0 packed cell  Hb ≥ 6.0 mmol / l = 0 packed cell  
5.0 - < 5.5 = 1 packed cell   5.5 - < 6.0 = 1 packed cell  
4.5 - < 5.0 = 2 packed cells   5.0 - < 5.5 = 2 packed cells  
< 4.5 = 3 packed cells    < 5.0 = 3 packed cells  
In all cases these are transfusion guidelines, of which the clinical presentation of the  
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Background. To retain or to sacrifice the posterior cruciate ligament (PCL) in total 
knee replacement (TKR) remains a matter of discussion. This systematic review aims 
to find differences in functional and clinical outcome between PCL retention and 
sacrifice. 
Methods. A systematic review and meta-analysis was conducted including all RCT’s 
and quasi RCT’s comparing PCL retention with PCL sacrifice in TKR with a minimum 
of 1 year follow-up. Primary outcome was range of motion. Secondary outcomes 
were knee pain and, preferably validated, clinical scoring systems (PROM’s). Quality 
of evidence was graded using the GRADE-approach. All outcomes available for data-
pooling were used for meta-analysis. 
Results. Twenty studies (1.877 patients, 2.347 knees) were included. In meta-
analysis the postoperative flexion angle had a mean difference of 2.1 degrees (95%-
CI 0.23, 3.98 p=0.03) and the KSS functional score was 2.4 points higher (95%-CI 
0.41; 4.30 p=0.02) in favor of PCL sacrifice. Analysis showed no further statistical 
difference with respect to other measured clinical outcomes like, WOMAC, KSS pain, 
clinical and overall score, HSS score, SF-12, radiolucencies, femoro-tibial angle, and 
tibial slope. The quality of the studies was highly variable with moderate to high risk 
of bias. 
Interpretation. There are no clinically relevant differences between PCL retention and 
PCL sacrifice in TKR in terms of functional and clinical outcomes. Quality of the 
studies ranged from moderate to low. Based on the current evidence no 





The debate whether to retain or to sacrifice the posterior cruciate ligament (PCL) 
during TKR surgery is ongoing. Arguments for PCL retention are maintenance of the 
natural movements of the knee while maintaining stability from extension to flexion.1,2 
Furthermore, the PCL is supposed to have different types of mechanoreceptors 
detecting joint position (proprioception) and joint motion (kinesthesia), thus the PCL 
might yield a better “sense“ of the postoperative knee.3,4 Retention of the PCL leads 
to the need of adequate balancing of the ligament. Inadequate balancing of the PCL 
(i.e. when the PCL is either too tight or too loose after placement of the TKR) leads to 
a deficient knee with pain, deteriorated range of motion and instability.5,6 On the other 
hand, sacrificing the PCL could be helpful in balancing knees with deformities or 
contractures. Another advantage of sacrificing the PCL is preventing paradoxal 
femoral rollback as demonstrated by PCL retaining implants.7 Femoro-tibial 
movement will then be dictated by the degree of congruency between the femur and 
the tibial insert.8 Sacrificing the PCL leads to an increase in the flexion gap and to a 
lesser extent an increase in the extension gap.2,9 A Cochrane systematic review in 
2005 could not indicate what treatment option is best regarding functional, clinical 
and radiological outcome parameters.10 An update of this review was published (in 
Cochrane) in 2013 still showing no relevant differences between both groups.11 
Since the aforementioned literature search, several new reports of randomized 
controlled trials (RCT’s) have been published that compare PCL retention with PCL 
sacrifice, necessitating an update of the current evidence. We aimed to find 
differences in functional, clinical and radiological outcome between PCL retaining 
and PCL sacrificing TKR within the current literature.   
Methods 
Literature search and study selection 
We used the same study protocol as developed for our Cochrane systematic review 
and meta-analysis.10,11 We conducted a sensitive search in order to retrieve all 
available literature. In consultation with an experienced librarian (JS) of the medical 
library of the Leiden University Medical Centre we searched the following databases: 






Background. To retain or to sacrifice the posterior cruciate ligament (PCL) in total 
knee replacement (TKR) remains a matter of discussion. This systematic review aims 
to find differences in functional and clinical outcome between PCL retention and 
sacrifice. 
Methods. A systematic review and meta-analysis was conducted including all RCT’s 
and quasi RCT’s comparing PCL retention with PCL sacrifice in TKR with a minimum 
of 1 year follow-up. Primary outcome was range of motion. Secondary outcomes 
were knee pain and, preferably validated, clinical scoring systems (PROM’s). Quality 
of evidence was graded using the GRADE-approach. All outcomes available for data-
pooling were used for meta-analysis. 
Results. Twenty studies (1.877 patients, 2.347 knees) were included. In meta-
analysis the postoperative flexion angle had a mean difference of 2.1 degrees (95%-
CI 0.23, 3.98 p=0.03) and the KSS functional score was 2.4 points higher (95%-CI 
0.41; 4.30 p=0.02) in favor of PCL sacrifice. Analysis showed no further statistical 
difference with respect to other measured clinical outcomes like, WOMAC, KSS pain, 
clinical and overall score, HSS score, SF-12, radiolucencies, femoro-tibial angle, and 
tibial slope. The quality of the studies was highly variable with moderate to high risk 
of bias. 
Interpretation. There are no clinically relevant differences between PCL retention and 
PCL sacrifice in TKR in terms of functional and clinical outcomes. Quality of the 
studies ranged from moderate to low. Based on the current evidence no 





The debate whether to retain or to sacrifice the posterior cruciate ligament (PCL) 
during TKR surgery is ongoing. Arguments for PCL retention are maintenance of the 
natural movements of the knee while maintaining stability from extension to flexion.1,2 
Furthermore, the PCL is supposed to have different types of mechanoreceptors 
detecting joint position (proprioception) and joint motion (kinesthesia), thus the PCL 
might yield a better “sense“ of the postoperative knee.3,4 Retention of the PCL leads 
to the need of adequate balancing of the ligament. Inadequate balancing of the PCL 
(i.e. when the PCL is either too tight or too loose after placement of the TKR) leads to 
a deficient knee with pain, deteriorated range of motion and instability.5,6 On the other 
hand, sacrificing the PCL could be helpful in balancing knees with deformities or 
contractures. Another advantage of sacrificing the PCL is preventing paradoxal 
femoral rollback as demonstrated by PCL retaining implants.7 Femoro-tibial 
movement will then be dictated by the degree of congruency between the femur and 
the tibial insert.8 Sacrificing the PCL leads to an increase in the flexion gap and to a 
lesser extent an increase in the extension gap.2,9 A Cochrane systematic review in 
2005 could not indicate what treatment option is best regarding functional, clinical 
and radiological outcome parameters.10 An update of this review was published (in 
Cochrane) in 2013 still showing no relevant differences between both groups.11 
Since the aforementioned literature search, several new reports of randomized 
controlled trials (RCT’s) have been published that compare PCL retention with PCL 
sacrifice, necessitating an update of the current evidence. We aimed to find 
differences in functional, clinical and radiological outcome between PCL retaining 
and PCL sacrificing TKR within the current literature.   
Methods 
Literature search and study selection 
We used the same study protocol as developed for our Cochrane systematic review 
and meta-analysis.10,11 We conducted a sensitive search in order to retrieve all 
available literature. In consultation with an experienced librarian (JS) of the medical 
library of the Leiden University Medical Centre we searched the following databases: 
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Medline (via PubMed), the Cochrane Central Register of Controlled Trials, Embase, 
Web of Science, CINAHL, Academic Search Premier, Current Contents Connect, 
and Science Direct. All databases were searched up to May 19th 2014 using an 
adapted syntax for every single database (Appendix table A). No restrictions or limits 
were formulated. A final check that no relevant articles were missed was carried out 
by screening the references from the articles and by performing citation tracking on 
the articles that were included.  
Articles were selected in two steps. In the first step only title and abstract were 
available. In the second step, articles which passed the first step were retrieved full 
text and again evaluated against the in-and exclusion criteria. These criteria were: 
 The intervention evaluated in the trials had to be primary TKR comparing PCL 
retention with sacrifice.  
 The indication for TKR had to be osteoarthritis.  
 Minimal follow-up had to be twelve months. 
 Studies had to be RCT’s or quasi RCT’s. Quasi RCT’s are studies using for 
example date of birth, patient identification numbers or alternating sequences 
for randomization. 
Two reviewers (WV, LB) independently selected the trials to be included in the 
review. Disagreements were resolved by consensus. When no consensus could be 
reached, a third reviewer (WJ) was available for the decisive vote. 
Data collection 
A pre-developed and tested data extraction form was used to extract data from the 
included studies. Items collected were study design features, population data, 
statistical analysis techniques, intervention characteristics and all reported outcome 
parameters, including results. The primary outcome was range of motion (ROM), 
including flexion and extension angle separately. Secondary outcomes were knee 
pain (Visual Analogue Scale, Knee Society clinical pain sub-score), validated clinical 
scoring instruments (such as Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC), Knee Osteoarthritis Outcome Scale (KOOS), Oxford 




(KSS), Hospital for Special Surgery score (HSS), etc.), radiological implant migration 
(preferably using radiostereometric analysis (RSA)), complication rate, and other 
radiological outcomes (such as rollback, radiolucencies). All data were entered into 
Review Manager 5.2 (The Cochrane Collaboration, 2012). 
The risk of bias (e.g. selection bias, performance bias, detection bias, attrition bias) 
was assessed for every study. The risk of selection bias was judged by assessing 
how the randomization sequence was generated and by assessing how the 
treatment allocation was concealed. Risk of performance-and detection bias was 
judged by evaluating the blinding methods of participants, personnel and observers, 
as described in the studies. Risk of attrition bias was assessed by judging the 
completeness of the data, including the follow-up rate. The possible judgements that 
could be made were low risk of bias, high risk of bias and unclear risk of bias. 
The quality of the evidence was assessed using the GRADE approach.12 In this 
method for grading quality, RCT’s are considered as high quality evidence; however 
this can be downgraded to moderate, low, or very low quality for several reasons. 
These reasons are study limitations (e.g. high risk of bias), inconsistent results, 
indirectness of evidence, imprecision or publication bias. The Cochrane collaboration 
recommends using this approach to grade the quality of studies in systematic 
reviews.13  
Analysis 
Statistical analyses were conducted using Review Manager 5.2. Continuous data 
were entered as means and standard deviations, dichotomous outcomes as number 
of events. Standard deviations were used when available. If not provided, standard 
deviations were imputed from comparable studies or from original scores (i.e. 
confidence intervals). In the meta-analysis, if the studies (patients, interventions, 
outcomes) were regarded to be clinically homogeneous, heterogeneity was first 
assessed by visual inspection of the forest plots. Furthermore it was investigated with 
the I2-statistic and, if significant (p<0.05 using the Q statistic), the source of 
heterogeneity was investigated by doing a sensitivity analysis and considering 
additional clinical reasons for potential clinical heterogeneity. In the absence of 
significant heterogeneity, and given sufficient included trials, results were combined 
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using mean differences for continuous data, and relative risk for dichotomous data. A 
random effects model was used for all analyses. 
Results 
A total of 2.609 unique references were identified. A total of 58 articles were selected 
for further evaluation, resulting in twenty-one full-text papers used for analysis 
(Figure 7.1, PRISMA flowchart).14-34  
 
 
The article of Victor et al. described a population that is also part of the study 
population of Harato et al.19,30 Data from both articles were used only once. The 
article from de Andrade et al. was written in Portuguese and the article from 
Yansheng et al. was written in Chinese.18,33 Data were extracted by professional 
translators. Characteristics of the studies are presented in table 7.1. 
  
Figure 7.1: Flow-chart study selection 
 
20 studies, reported in 
21 articles 
58 references selected for 
full-text evaluation 
 
2.609 unique references 
identified 
38 of full-text articles excluded 
- Not randomized: 18 
- Congress proceedings: 5 
- No posterior cruciate ligament sacrifice 
vs retention: 5 
- Follow-up < 1 year: 4 





The twenty studies included 1.877 patients and 2.347 knees. In seventeen studies 
the comparison between the two arms was PCL retention with a cruciate-retaining 
design versus PCL-sacrifice using a posterior stabilized design.14-22,25,28,29,30-34 In 
three studies the same (cruciate-retaining) TKR design was used for both 
groups.23,24,26 One study used all three treatments (i.e. cruciate retaining design with 
ligament retention and with ligament sacrifice and posterior stabilized design.27 
All studies used a clinical rating scale, either well-validated (e.g. WOMAC) or less 
validated (e.g. Knee Society Score or Hospital for Special Surgery score) and 
reported range of motion or flexion measurements. The report of radiostereometric 
analyses (RSA) was scarce.  
Risk of bias and quality of evidence 
Twenty-five percent of the included studies were assessed as having ‘low risk of 
bias’. Five studies (25%) described how the randomization sequence was 
generated.16,19,23,24,29 The method of concealment of allocation was reported in six 
studies (30%).16,19,20,22,25,29 Three studies used quasi-randomization; Aglietti et al. 
based treatment choice on odd/even patient identification numbers, Maruyama et al., 
used alternating sequences and Wang et al. used hospital admission moment to 
base treatment on.14,21,31 Blinding of the outcome assessor was reported in ten 
studies.14,16,18,20,22,23,25,27-29 Seon et al. explicitly reported that no blinding was 
applied.25  
Studies reporting on the primary outcome of knee flexion were graded according to 
the GRADE approach. These studies were assessed, on average, as being of low 
quality. Quality was downgraded due to the high amount of studies with unclear risk 
of bias and the presence of studies rated with high risk of bias. Also studies reporting 
on the secondary outcomes were graded as being of average to low quality. 
Meta-analysis 
There is low quality of evidence from twelve studies (1.056 knees) that PCL sacrifice 
results in a better flexion angle, with a mean difference of 2.1 degrees (95%-CI 0.2; 
4.0, p=0.03). This is a homogeneous result (I2 =29%, p=0.16). Furthermore, there is 
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low quality of evidence from nine studies (1.530 knees) that PCL sacrifice results in a 
higher Knee Society Score functional score of 2.4 points (95%-CI 0.4; 4.3 p=0.02) 
(Figure 7.2). These are the only homogeneous and statistically significant differences 
between PCL retention and sacrifice. The WOMAC score was used in five studies; 
there was a 0.7 points difference between both groups (95%-CI -0.4; 1.8, p=0.19) in 
favor of PCL sacrifice. See Figure 7.2.  
Figure 7.2: Forest plots. A. Knee flexion from all PCL sacrificing and retaining TKR’s. B. Knee 
flexion from PCL retaining design vs. PS design. C. Knee Society Score functional score           





















No other validated scoring systems were available for meta-analysis. Meta-analyses 
on the outcomes: KSS pain, KSS clinical score, KSS overall score, HSS score, SF-12 
mental, radio-lucent lines, femoro-tibial angle, and tibial slope showed no significant 
differences and were comparable in terms of statistical homogeneity.     
Sub-analyzing outcomes of low quality studies comparing PCL retention with 
sacrifice using the same, PCL-retaining, TKR design in both groups, showed no 
significant differences. Comparing knee flexion in PCL retention with the PCL 
sacrificing PS design ten studies of moderate quality (746 knees) demonstrated a 2.8 
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Complications were reported in twelve studies.14-16,19-24,29,32,33 Reported complications 
ranged from anterior knee pain and femoral notching to deep infection. Table 7.2 lists 
the complications per study. 
Table 7.2: Complications reported in the selected studies 
Study PCL retention PCL sacrifice 
Aglietti 2005  None Septic loosening: 1 
Catani 2004  
 
Anterior knee pain: 1 
Limited ROM: 1 
Anterior knee pain: 2 
Chaudhary 2008  Deep infection: 1 Limited ROM: 1 
Harato 2008  
 
Stiff knee ( < 900 flexion): 7 
Knee pain: 5    
Infection: 1 
Stiff knee: 1  
Knee pain: 2 
Infection: 3 
Kim 2009  
 
Femoral notching: 2 
Superficial infection: 1 
Femoral notching: 3 
Superficial infection: 1 
Maruyama 2004 None None 
Matsumoto 2012 None Deep venous thrombosis: 1 
Misra 2003  
 
Stiff knee  (< 300 flexion): 2 
Infection: 1 
Aseptic loosening: 2 
Instability: 3 
Stiff knee: 2 
Aseptic loosening: 3 
Dystrophy: 1 
Instability: 3 
Roh 2012 PCL laxity: 2 
PCL tightness: 1 
None 
Thomsen 2013  Infection: 1 None 
Yagishita 2012 None Deep venous thrombosis: 1 
Yansheng 2013 None None 
PCL = posterior cruciate ligament, ROM = range of motion 
 
Discussion 
In this study of the current literature comparing PCL retention with PCL sacrifice in 
TKR no clinical relevant differences were seen between the two TKR groups. Based 
on the data of the 1.877 patients (2.347 knees) in twenty RCT’s, a statistical 




the Knee Society functional score, both in favor of the PCL sacrifice, which are not 
clinically relevant. Furthermore, the RCT’s were graded having low to moderate 
quality of evidence. This study was performed according to the Cochrane guidelines 
a described in the Cochrane Handbook for Systematic Reviews.13 An extensive 
report on this topic analyzing seventeen studies, was published by our group in 2013 
within the Cochrane library of systematic reviews, the newly added studies did not 
add new evidence on this topic.11 
The twenty selected studies are the best available evidence to date to evaluate the 
difference between PCL retention and PCL sacrifice in TKR. The assessment of the 
quality of the evidence showed that evidence was low to moderate. Incompleteness 
of reporting issues such as failure to quote randomization methods and blinding 
raises the likelihood of bias in the studies resulting in lower quality of evidence 
grades. However, an improving trend in reporting is seen, as the chronologically 
more recent publications were generally assessed as having a lower risk of bias.  
Despite the fact that RCT’s are qualified as providing the least biased evidence they 
are not suited for all outcomes. Survival analysis of the TKR cannot be easily 
investigated by RCT’s, and in addition classic survival analyses can be biased by 
competing risks, which should be issued for valid outcome interpretation.35,36 
Observational, long-term follow-up cohort studies are valuable alternatives. 
Survivorship analyses of, relatively large cohorts, showed a ten-or fifteen year 
survival of 91% and 90% respectively in the PCL retaining group and 76% and 75% 
in the PCL sacrificing, posterior stabilized group.37,38 However, other factors could 
influence these results such as differences in TKR design or materials between PCL 
retaining and stabilizing components.39 A minimum data set for cohort studies has 
been advocated by the AQUILA consortium.40 Furthermore, a topic under-discussed 
in the current RCT’s on PCL retention versus sacrifice in TKR is the issue of 
secondary anterior-posterior instability due to secondary insufficiency of the PCL. 
Probably because no long term follow-up reports of RCT’s are published, this issue 
has not been described.  
This study has several strengths. We used a very sensitive search in eight relevant 
databases with no language limitations. We also checked references and used 
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citation tracking. Recently published meta-analyses found and included only between 
eight and twelve articles instead of twenty-one.41-43 We excluded several RCT’s 
because of follow-up less than a year.4,44-46 Since our study was performed according 
to the Cochrane guidelines, an elaborate and systematic assessment of quality of 
evidence and risk of bias was performed. In the meta-analysis we analyzed the 
subgroups of PCL sacrifice using a PCL retaining design and PCL sacrifice using a 
posterior stabilized design versus PCL retention separately.  
A limitation is the lack of high quality evidence in meta-analysis. Furthermore we 
could not present information on outcome measures like patient experience and 
satisfaction, gait analysis, micro-motion of the components (RSA) and kinematic 
outcomes measures such as antero-posterior stability and contact position. The 
importance of the predictive value of RSA and survival in TKR had been extensively 
analyzed.47,48 
Future research in the field of PCL retention or sacrifice in TKR should consist of 
RCT’s that have identical follow-up moments, that include long(er) term follow-up in 
their protocols and that add outcome measures such as patient experience and 
satisfaction, gait analysis, antero-posterior stability of the knee, and contact position. 
To study long-term TKR survival or complications large observational studies are 
needed focusing on PCL retention versus sacrifice. Furthermore reporting of future 
studies have to be more complete in describing study methods in order to reduce the 
likelihood of bias and should also mention important confounders for outcome like 
preoperative ROM measurements. 
Conclusion 
Based on this systematic review and meta-analysis of all currently available RCT’s 
there are no clinically relevant differences between retention or sacrifice of the PCL 
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citation tracking. Recently published meta-analyses found and included only between 
eight and twelve articles instead of twenty-one.41-43 We excluded several RCT’s 
because of follow-up less than a year.4,44-46 Since our study was performed according 
to the Cochrane guidelines, an elaborate and systematic assessment of quality of 
evidence and risk of bias was performed. In the meta-analysis we analyzed the 
subgroups of PCL sacrifice using a PCL retaining design and PCL sacrifice using a 
posterior stabilized design versus PCL retention separately.  
A limitation is the lack of high quality evidence in meta-analysis. Furthermore we 
could not present information on outcome measures like patient experience and 
satisfaction, gait analysis, micro-motion of the components (RSA) and kinematic 
outcomes measures such as antero-posterior stability and contact position. The 
importance of the predictive value of RSA and survival in TKR had been extensively 
analyzed.47,48 
Future research in the field of PCL retention or sacrifice in TKR should consist of 
RCT’s that have identical follow-up moments, that include long(er) term follow-up in 
their protocols and that add outcome measures such as patient experience and 
satisfaction, gait analysis, antero-posterior stability of the knee, and contact position. 
To study long-term TKR survival or complications large observational studies are 
needed focusing on PCL retention versus sacrifice. Furthermore reporting of future 
studies have to be more complete in describing study methods in order to reduce the 
likelihood of bias and should also mention important confounders for outcome like 
preoperative ROM measurements. 
Conclusion 
Based on this systematic review and meta-analysis of all currently available RCT’s 
there are no clinically relevant differences between retention or sacrifice of the PCL 
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Appendix table A: Syntax used for Medline search 
Search strategy syntax adopted for Medline (Pubmed) 
("Arthroplasty, Replacement, Knee"[Mesh] OR "Knee Prosthesis"[Mesh] OR "knee replacement 
arthroplasty"[tw] OR "total knee arthroplasty"[tw] OR "total knee"[tw] OR tka[tw] OR "total knee 
replacement"[tw] OR "knee prosthesis"[tw] OR "knee implantation"[tw] OR "knee implant"[tw] OR "knee 
implants"[tw] OR "knee prosthesis"[tw] OR "knee joint replacement"[tw] OR "knee joint arthroplasty"[tw] OR 
tkr[tw] OR "Knee Replacement Arthroplasties"[tw] OR "Total Knee Replacements"[tw] OR "Knee 
Prostheses"[tw] OR "Knee endoprosthesis"[tw] OR "Knee endoprostheses"[tw] OR "Knee joint 
arthroplasty"[tw] OR "Knee joint arthroplasties"[tw] OR "knee joint prosthesis"[tw] OR "knee joint 
prostheses"[tw] OR "knee prosthetic"[tw] OR "Knee endoprosthetic"[tw] OR "knee joint prosthetic"[tw] OR 
"Knee joint endoprosthetic"[tw] OR "knee prosthetics"[tw] OR "Knee endoprosthetics"[tw] OR "knee joint 
prosthetics"[tw] OR "Knee joint endoprosthetics"[tw] OR "Knee replacement"[tw] OR "Knee replacements"[tw] 
OR "knee arthroplasty"[tw] OR "knee arthroplasties"[tw])  
AND  
("osteoarthritis"[Mesh] OR "arthritis"[Mesh] OR "posterior cruciate ligament"[Mesh] OR Osteoarthrosis[tw] OR 
Osteoarthroses[tw] OR Osteoarthritides[tw] OR Osteoarthritis[tw] OR Osteoartrosis[tw] OR Osteoartroses[tw] 
OR Osteoartritides[tw] OR Osteoartritis[tw] OR Degenerative Arthritis[tw] OR Degenerative Arthritides[tw] OR 
Degenerative Artritis[tw] OR Degenerative Artritides[tw] OR Arthrosis[tw] OR Arthroses[tw] OR Arthritides[tw] 
OR Arthritis[tw] OR arthritic[tw] OR RA[tw] OR rheumatoid[tw] OR rheumatic[tw] OR Artrosis[tw] OR 
Artroses[tw] OR Artritides[tw] OR Artritis[tw] OR Osteoarthrosis Deformans[tw] OR Osteoartrosis 
Deformans[tw] OR Posterior Cruciate Ligament[tw] OR Posterior Cruciate Ligaments[tw] OR Cruciate[tw] OR 
PCL[tw]) 
AND  
("randomized controlled trial"[Publication Type] OR "randomized controlled trials as topic"[Mesh] OR "random 
allocation"[Mesh] OR "double-blind method"[Mesh] OR "single-blind method"[Mesh] OR "placebos"[Mesh] OR 
random*[tw] OR ramdom*[tw] OR ramdon*[tw] OR randon*[tw] OR rct[tw] OR rct's[tw] OR rcts[tw] OR 
((single[tw] OR double[tw] OR treble[tw] OR triple[tw]) AND (mask*[tw] OR blind*[tw])) OR placebo*[tw] OR 
random*[tw] OR compare*[ti] OR versus[ti] OR vs[ti]) 
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("randomized controlled trial"[Publication Type] OR "randomized controlled trials as topic"[Mesh] OR "random 
allocation"[Mesh] OR "double-blind method"[Mesh] OR "single-blind method"[Mesh] OR "placebos"[Mesh] OR 
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Introduction. After primary total knee/hip replacement (TKR or THR respectively) a 
prosthetic joint infection could develop. Hypothermia could raise the risk of infection. 
Heating by forced-air can disrupt laminar airflow at the operation room (OR), 
potentially raising the risk of infection. We aimed to study non-inferiority of an active 
self-heating blanket (BARRIER EasyWarm, BE) compared to a forced-air blanket 
(BairHugger, BH) in preventing hypothermia.  
Methods. A randomized controlled non-inferiority trial (N=86 patients) was performed 
comparing BE versus BH in elective primary TKR/THR patients. Primary outcome 
was lowest measured temperature during surgery. Secondary outcomes were 
patients’ core temperature before, during and after surgery, thermal comfort visual 
analogue score (VAS) and complications during hospitalization. 
Results. Lowest measured temperature was 35.9°C(±0.6) in BE and 36.1°C(±0.5) in 
BH group (p=0.05). No significant correlation was found with duration of surgery or 
temperature of the OR. No significant difference in core temperature was found 
before surgery (BE 36.8°C±0.4, BH 36.8°C ±0.5, p=0.49), after induction of 
anesthesia (BE 36.6°C±0.5, BH 36.7°C ±0.5, p=0.22) nor as a mean during surgery 
(BE 35.8°C±1.6, BH 36.0°C±1.3, p=0.68). BE patients were ‘colder’ at the recovery 
bay, 35.8°C(±0.6) compared to BH patients, 36.1°C(±0.5) (p=0.04). Mean VAS 
thermal comfort was 53.3(±15.7) in BE and 52.9(±12.3) in BH patients. No difference 
in complication rate was found.  
Conclusion. In this study both warming blankets did not prevent perioperative 
hypothermia.  Although a difference of 0.2oC was found between both groups at the 
end of TKR/THR surgery, this is most probably not clinical relevant. Complication 





Most general anesthetics impair thermoregulatory responses resulting in mild 
hypothermia.1 Mild hypothermia, defined as a body temperature between 34.0 and 
36.0 degrees Celsius (oC), during primary total knee or hip replacement surgery (TKR 
or THR respectively) is  associated with adverse events.2 Studies showed that mild 
hypothermia might result in more postoperative discomfort, prolonged length of 
hospital stay, higher risk of myocardial infarction and a higher risk of surgical site 
infection.3-5 This is why warming of joint replacement patients has become routine 
practice. Several strategies can be used to warm patients during surgery; two 
commonly used techniques are active warming by forced-air devices or warming 
using self-warming blankets.6,7  
Clean laminar airflow in operating rooms is considered to reduce the risk of infection 
in TKR or THR surgery.8 This downward directed airflow has shown to be disrupted 
by forced-air warming devices when hot air moves upwards against this downward 
air current.8,9 Furthermore, this upwards directed air current has could potentially 
induce prosthetic joint infection (PJI) by creating air currents with a downward 
directed flow on the operating field.10  
In an effort to further reduce the risk of developing prosthetic joint infection we 
hypothesized that using a self-warming blanket would keep the core temperature of 
the patient at the end of surgery at the same level as the forced-air devices, but with 
the advantage that no air currents were present or disturbed. So we aimed to study 
the non-inferiority of the self-warming blanket compared to the, more frequently used, 
forced-air warming. 
Methods 
This prospective, randomized controlled, single-center non-inferiority trial was 
approved by the Medical Ethics Committee (METC ZWH, no.17-049). The trial was 
registered in the Dutch Trial Registry (NTR6495).  
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Inclusion took place between June and August 2017. All consecutive patients who 
were planned for primary TKR or THR surgery, older than 18 years of age and able 
to speak and understand the Dutch language were considered eligible and were 
asked to participate in the study. They were included after signing informed consent. 
Patients with severe peripheral arterial disease were excluded from the study. All 
surgeries were performed in one large general training hospital in the Netherlands.  
Intervention 
Participants were randomized to one of two treatment groups; 
1. Forced-air warming using the Bair Hugger™ device (3M Co. St.Paul, MN, 
USA) 
2. Self-warming blanket BARRIER EasyWarm™ (Mölnlycke Health Care AB, 
Götenborg, Sweden) 
At the ward all participants received the self-warming blanket to pre-heat before 
going to the operating room (which is standard protocol of care at our institution). At 
the anesthesiology bay patients received the SpotOn™ (3M Co. St.Paul, MN, USA) 
thermometer.11 This is a non-invasive device continuously measuring and recording 
core body temperature.11 All data were directly saved into the electronic patient-care 
system. At the end of the surgery tympanic temperature was recorded as well. 
Patients in both groups were operated on according to the standard protocol for TKR 
or THR. In case of THR the patient was supine and the direct anterior approach was 
used in all cases. In case of TKR patients were also supine and the median incision, 
medial parapatellar approach was used in all cases. Both warming systems were 
applied on the upper part of the body of the patient in a way that most of the skin was 
covered by the blanket. Temperature of the operating room during all procedures 
was recorded continuously. Upon return of the patient at the postoperative recovery 
bay a visual analogue scale (VAS) regarding temperature comfort experience was 







Primary outcome was the lowest temperature measured during surgery.  
Secondary outcomes measures were core temperature preoperatively at the holding, 
after induction of anesthesia, intraoperatively and postoperatively at the recovery 
ward. Also tympanic temperature at the end of surgery, the total number of 
measurements <36.0°C, thermal comfort VAS and complications during 
hospitalization were recorded.  
Randomization 
Allocation of treatment sequence was generated by a computer using Castor EDC 
data management software (Castor EDC, Amsterdam, the Netherlands). Variable 
block randomization was used with block sizes of 2, 3 or 4. Before entering the OR-
center the bed of the patient was tagged with the allocated treatment. Blinding during 
surgery was not possible due to the obvious differences between the two warming 
systems. Investigators assessing outcomes were blinded for treatment allocation. 
Statistical analysis 
Statistical analyses were performed using SPSS Statistics for Windows, version 24.0. 
(Armonk, NY: IBM Corp.) To calculate sample size, a power analysis for equivalence 
(unpaired test) was performed. Based on Brandt et al. (2010) lower and upper 
equivalence bounds were ±0.5°C, with a standard deviation of 0.6°C. To achieve a 
power of 90% to detect equivalence within the equivalence bounds of ±0.5°C, a total 
sample size of 40 patients per group (80 patients) was estimated, including loss of 
follow-up. The primary outcome was analyzed by a TOST (two-one sided test), a test 
of equivalence that is based on the classical t-test used to test the hypothesis of 
equality between two means, as well as an independent sample t-test.12 
Demographic variables, secondary outcomes regarding to core temperatures and 
thermal comfort (VAS) were calculated with independent samples t-test. To 
determine correlations between the lowest mean preoperative core temperature and 
OR temperature or duration of surgery a logistic regression analysis was performed. 
Dichotomous variables were calculated by chi-squared test. Results are expressed in 
means ± standard deviation or 95% confidence intervals (95%-CI). Differences were 
considered statistically significant at p<0.05.  
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From 90 consecutive patients 86 were randomized to receive one of the two warming 
systems (Figure 8.1). All patients were treated according to allocation. Table 8.1 
shows baseline characteristics per treatment group. Groups were comparable in 
terms of demographic and clinical characteristics.  
Table 8.1: Baseline characteristics 




Age  years (SD) 71.2 (10.1) 72.1 (10.9) 
Gender  (male/female) 15/28 15/27 
Body Mass Index  kg/m2 (SD) 27.7 (3.8) 28.3 (4.5) 
Diabetes Mellitus  (type1/type2/none) 0/3/40 0/3/39 
Cardiovascular diseases  N (%) 26 (60) 11 (26) 
Anesthesia    
General  (N)  8 11 
Spinal  (N) 35 31 
Procedure   
Total hip replacement  (N) 27 23 
Operated side  (left/right) 13/14 7/16 
Total knee replacement  (N) 16 19 
Operated side  (left/right) 5/11 7/12 
Tourniquet  (yes/no) 5/11 5/18 
Tourniquet time  min(SD)  18.8 (17.8) 19.0 (12.4) 
Duration of surgery  min (SD) 69.9 (18.6) 65.8 (16.0) 
Duration of anesthesia  min (SD) 89.8 (21.8) 88.8 (18.7) 
Blood loss  (mL) 199 (253) 164 (228) 
OR temperature start  °C (SD) 18.6 (0.4) 18.6 (0.4) 
OR temperature end  °C (SD) 18.6 (0.4) 18.6 (0.4) 
SD: Standard deviation 
Table 8.2 shows outcome measures. For the primary outcome; the mean lowest 
measured core temperatures were respectively 35.9(±0.6)°C for the BARRIER 
EasyWarm (BE) group and 36.1(±0.5)°C for the Bair Hugger (BH) group.  
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A secondary non-inferiority test (TOST) showed non-inferiority of the BE in relation to 
the predetermined delta of 0.5°C. In relation to the zero-point (i.e. no difference 
between BE and BH) the BE is just inferior by 0.2°C.  
No correlation was shown between the mean lowest measured core temperature 
during surgery and the duration of surgery (p=0.12), nor with the temperature in the 
operation room (OR) at the start or end of the operation (p=0.11 and p=0.06 
respectively). Mean core temperature before surgery did not differ significantly 
between the two groups (p=0.49), nor did mean core temperature after induction of 
anesthesia (p=0.22), at the start of surgery or mean core temperature during surgery 
(p=0.68). A significant difference (p=0.02) in core temperature was found at the end 
of surgery, 35.9°C ±0.6 for the BARRIER EasyWarm group and 36.2°C ±0.5 for the 
Bair Hugger group. After surgery, at the recovery bay, the BE group was ‘colder’ 
compared to the BH group, 35.8°C ±0.6 and 36.1°C ±0.5 respectively (p=0.04). 
Figure 8.2 shows mean core temperature during surgery. 








Mean core temperature holding  °C (SD) 36.8 (0.4) 36.8 (0.5) 0.49 
Mean core temperature after induction of anesthesia  °C (SD) 36.6 (0.5) 36.7 (0.5) 0.22 
Core temperature start  °C (SD) 36.3 (0.5) 36.4 (0.5) 0.56 
Mean intraoperative core temperature °C (SD) 35.8 (1.6) 36.0 (1.3) 0.68 
Mean lowest peroperative core temp  °C (SD) 35.9 (0.6) 36.1 (0.5) 0.05 
Core temperature end  °C (SD) 35.9 (0.6) 36.2 (0.5) 0.02 
Mean core temperature recovery  °C (SD) 35.8 (0.6) 36.1 (0.5) 0.04 
Measurements <36°C  N (%) 26 (60) 15 (38) 0.24 
Measurements <36°C (n) 2.6 ± 2.5 2.0 ± 2.7 0.32 
Complication during hospitalization (yes/no) 2/41 2/41 1.0 
Thermal comfort VAS  mean (SD) 53.3 (15.7) 52.9 (12.3) 0.90 
All temperatures are in 0C. SD = standard deviation, VAS = visual analogue scale, rang from 0 (extreme cold) to 
100 (extreme hot). 




Figure 8.2: Mean perioperative core temperature 
  
Measurements below 36.0°C were seen in both groups (BE: 26/43 (60%), BH: 15/40 
(38%) p=0.24) and the number of measurements below 36.0°C was comparable; 2.6 
±2.5 for the BE group and 2.0 ±2.7 for the BH group (p=0.32). Tympanic temperature 
measurement showed a mean difference of approximately 0.1°C (range -1 – 1.1) 
compared to the SpotOn core thermometer. Evaluation of patients’ experienced 
thermal comfort, using a Visual Analogue Scale (VAS), showed no differences 
between both groups (p=0.90). The mean VAS was 53.3 ±15.7 in the BE group and 
52.9 ±12.3 in the BH group. The number of complications was equal between both 
groups. In each group two complications during hospital stay occurred. In the BE 
group one THR treatment was complicated by persistent wound leakage 
postoperatively. CRP (44) and BSE (31) were elevated. This resulted in surgical 
debridement and microbial cultures were taken two weeks after the primary surgery. 
Cultures showed growth of enterococcus faecalis and staphylococcus lugdunensis. 
The patient was treated with intravenous vancomycin and rifampicin and subsequent 
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in the BE group had a history of hemorrhagic stroke. Postoperative clinical signs of 
aphasia, which was a result of a cerebral infarction, was seen. Acetylsalicylic acid 
and dipyridamole were started for secondary prophylaxes.  
In the BH group one THR patient had persistent wound leakage postoperatively. Lab 
results, showed elevated infection parameters (CRP44, BSE93), which gradually 
decreased during the postoperative period in several days. The patient was 
discharged without antibiotics or other intervention. Follow-up showed no infection. 
The other complication in the BH group had also THR. Several days after surgery, 
the patient was evaluated for tachypnea and hypotension. High infection parameters 
(CRP222, BSE56) and fever were present, the patient was diagnosed with a urinary 
bladder infection. Antibiotics were started. The patient improved clinically and was 
discharged to a temporary rehabilitation clinic.  
Discussion 
Both intraoperative patient warming methods failed to prevent hypothermia from 
occurring during the perioperative phase in our study. Measurements below 36.0oC 
were seen in 60% of the patients in de BE group as well as in 38% in the BH group. 
The results show that the self-warming blanket (BE) is less effective compared to the 
forced air blanket (BH) at the end of surgery and postoperatively at the recovery bay. 
It is important to consider whether the differences between both systems are 
clinically relevant because apparently both methods failed to prevent hypothermia.  
The complications, that occurred in both groups, might be related to hypothermia. 
Hypothermia affects the immune system. Decreased cell-mediated immunity and NK-
cell activity, suppression of B lymphocytes and defective function of T lymphocytes is 
seen due to hypothermia.13,14 There is also an association with suppressed 
phagocytic activity and reduced bacterial killing. It could be possible that hypothermia 
contributes to the immune alterations perioperatively and thereby increase the risk of 
postoperative complications.13,14  
Comparing both groups, no differences in complications related to the surgery were 
seen during hospital stay. Hypothermia, which could be a result of temperature 




is difficult to manage with passive methods, making active warming necessary. High 
incidences of postoperative hypothermia are seen in THR and TKR.5,15 Because 
hypothermia could result in several complications it should be managed properly.2 
There are different active warming methods, but for each of them their safety and 
efficacy should be questioned.  
The Bair Hugger system has widely been used in studies on perioperative warming.16 
In contrast to the Bair-Hugger, the BARRIER EasyWarm system is quite new. A 
randomized study showed that the BE system was superior to passive thermal 
insulation.17 However, another randomized study reported that a thermal reflective 
blanket was not able to prevent hypothermia during surgery.16 This finding is 
consistent with our study. Fanelli et al. randomized 56 patients undergoing elective 
THR to be warmed either by a forced-air system or by a resistive heating blanket.6 
Primary outcome was temperature as measured by tympanic thermometer. No 
significant differences were found, mild hypothermia was found in both groups at the 
end of surgery.6 A Cochrane systematic review and meta-analysis comparing forced-
air with active resistive heating was unable to show differences in terms of thermal 
comfort and also in terms of postoperative blood loss.16   
This study has several strengths and limitations. In this single-center randomized 
controlled non-inferiority trial we were able to randomize 86 of 90 consecutive TKR 
and THR patients without any loss to follow-up. Core temperature from all patients 
was measured in a uniform way. The reliability of tympanic temperature 
measurement is questioned with regard to accuracy compared to core temperature.18 
A relevant difference between both recording methods was not found. One factor that 
might compromise generalizability is that all THR patients were operated in a supine 
position via the direct anterior approach while the lateral decubitus position is still 
more frequently used in hip replacement surgery.  
Another possible limitation of our study is that a considerable amount of patients 
dropped below a temperature of 36.0 oC. The inability to prevent hypothermia in the 
BE group could be the result of a deviating use of the blanket; the BE was not directly 
placed on the patient as instructed by the manufacturer; a cotton blanket was placed 
in between and could have limited the penetration of warmth towards the patient, the 
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warmth has to penetrate this cotton blanket before reaching patient’s skin. Possibly 
prevention of hypothermia could have be better without placing this cotton blanket in 
between, as instructed by the manufacturer. The reason to use this interposing 
cotton blanket was prevention of burn lesions to the skin. To optimize the use of the 
BH, the operators’ manual cites to use a cotton blanket on top of it, in our study the 
Bair Hugger was used without blanket. Another factor, applicable for both groups, is 
that the patient could not be fully covered by the BE nor the BH due to the sterile 
field, with a larger uncovered field during THR compared to TKR.  
One of the potential advantages of the BE self-warming blanket is the possibility to 
use it continuously; before, during and after surgery, there is a constant active 
warming of the patient possible without interruption. The BH was turned on as soon 
as the sterile draping procedure was finished, the time during which the patient was 
moved from the bed to the operating table until finishing the sterile draping procedure 
of the surgical site no active warming was used for the patient.  
An advantage for the surgical team of a self-warming blanket over a forced-air 
blanket is the comfort of the operating team during surgery. A forced-air device has 
continuous flow of warm air affecting the surrounding air, if it is close to the operating 
staff it could feel quite ‘hot’. The warmth that a self-warming blanket generates 
remains close to the patient, possibly less affecting the surrounding air and thereby 
operating staffs’ comfort. Another factor affecting the staff’s comfort is the amount of 
noise in the OR; it goes without saying that a blanket is quiet while forced-air devices 
contribute to noise pollution in the OR.16 
Conclusion 
In this study both warming blankets did not prevent hypothermia from occurring in 
both the self-warming blanket group as well as in the forced-air blanket group. A 
statistical significant difference between both groups was found in core temperature 
at the end of TKR or THR surgery. Whether the difference of 0.2 oC is clinically 
relevant remains to be evaluated, it was nevertheless less than the hypothesized 




blanket was non-inferior to the forced-air blanket. But since many patients in both 
groups showed hypothermia, this should be addressed better.  
At the end of surgery and at the recovery room the BE group had significant, 
although little, lower core temperatures, whether such a small difference is clinically 
relevant remains to be discussed. 
We should ask ourselves the question if it is more important to keep the patient 
normothermic by using the BH with slightly better results, but with the risk of an 
infection due to interruption of the laminar flow and thereby affecting the sterile field. 
Perhaps it would be better to optimize the BE protocol, without interrupting the air 
flow and thereby reducing the risk of infection. However, hypothermia is also 
associated with infections. Both aspects, managing normothermia and avoiding 
interruption of laminar air flow, should be optimized to reduce the risk of infection and 
therefore further research is needed.   
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The number of Total Knee Replacement (TKR) surgeries performed in the 
Netherlands per year is growing, from about 20.000 in 2010 to about 28.000 in 2016, 
an increase of 40% (www.lroi.nl). TKR is the end-stage treatment for symptomatic 
osteoarthritis (OA) of the knee. The performance of orthopedic implants is 
traditionally measured by a mean survival rate after a certain period of time. Since 
survival rates for TKR are quite good in general (i.e. mean survival after 10 years is 
about 90% for the endpoint “revision surgery”), other patient related outcome 
measures, such as patient satisfaction or quality of life, are becoming increasingly 
important.1 In chapter 2 long-term patient satisfaction and quality of life (where long 
term is considered ten years or more after primary surgery) are reported after total 
knee or hip replacement (THR). Interestingly, patients are less satisfied after TKR (up 
to 20-25%) than after THR. The latter might be related to the indication for surgery. 
Patients with little preoperative radiological osteoarthritis of the knee (Kellgren & 
Lawrence grade 1 or 2) perform in general less compared to patients with more 
severe radiological OA of the knee. Other factors, like pain sensitization are 
important to take in consideration too, when indicating for total joint replacement 
during the shared decision making process with the patient. 
 
This thesis can be divided into two parts; in the first part we analyzed which patient 
receives a TKR and which patient does not, what is the timing and what is the 
outcome  at patient level. In the second part we studied how to improve the TKR 
surgery as a procedure; what can be done (or not) to improve TKR treatment. 
Part 1 – on patient selection 
The indication, and thus patient selection, to perform TKR is a major driver for 
outcome and thus for differences in postoperative patient satisfaction. No clear 
guidelines exist for the indication of TKR, except the presence of “enough pain”.2 In 
order to get an idea when TKR is recommended in the Netherlands we performed a 
study asking  all Dutch orthopedic surgeons whether they would perform TKR or not 
in three different cases (chapter 3). It seemed that radiological OA grade and old 
age were important factors to recommend TKR in daily clinical practice. For Dutch 




radiological OA grade), seemed not that important. In chapter 4 Dutch orthopedic 
surgeons recommending TKR or THR are compared to their colleagues from several 
other countries. Using data from over 1.900 patients from nine different countries it 
was found that TKR was less frequently recommended by Dutch orthopedic 
surgeons. Furthermore Dutch patients had the highest preoperative (joint related) 
quality of life.  
In chapter 5 results from the Leiden 85+ study are reported on functional 
performance of the oldest old patients (i.e. 85 years and older) who had a TKR or 
THR in the past. The functional level and health status of the oldest old with total joint 
replacement was comparable with the oldest old patients without joint replacement 
surgery at twelve years of follow-up.  
Osteoarthritis 
The development of OA is a complex process, involving genomics, metabolomics 
and environmental risk factors invoking molecular changes- and structural changes 
of cartilage and subchondral bone, with subsequent destruction of the joint.3 
Molecular interactions between cartilage, subchondral bone and synovial membrane 
play an important role in the pathogenesis of OA.3 Metalloproteases (MMP’s) are 
believed to play an important role in cartilage degeneration (e.g. MMP-13).4 
Furthermore several pro-inflammatory cytokines (i.e. IL-1β) and cartilage 
regeneration factors such as tumor growth factor β (TGF- β), insulin-like growth factor 
(IGF-1) and bone morphogenic proteins (BMPs) are extensively studied for their role 
in the development of OA.4,5 Also other cell types, like mast cells, are suggested to 
play a role in OA.6 Another factor contributing to the development of knee OA is 
overweight, via not entirely clear mechanisms. Limb alignment is also a factor, where 
valgus alignment increases the odds of lateral progression of OA and varus 
alignment medial progression. The presence of intra-articular damage in the history 
of the knee, ranging from isolated meniscal tear to anterior cruciate ligament rupture 
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Osteoarthritis 
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and environmental risk factors invoking molecular changes- and structural changes 
of cartilage and subchondral bone, with subsequent destruction of the joint.3 
Molecular interactions between cartilage, subchondral bone and synovial membrane 
play an important role in the pathogenesis of OA.3 Metalloproteases (MMP’s) are 
believed to play an important role in cartilage degeneration (e.g. MMP-13).4 
Furthermore several pro-inflammatory cytokines (i.e. IL-1β) and cartilage 
regeneration factors such as tumor growth factor β (TGF- β), insulin-like growth factor 
(IGF-1) and bone morphogenic proteins (BMPs) are extensively studied for their role 
in the development of OA.4,5 Also other cell types, like mast cells, are suggested to 
play a role in OA.6 Another factor contributing to the development of knee OA is 
overweight, via not entirely clear mechanisms. Limb alignment is also a factor, where 
valgus alignment increases the odds of lateral progression of OA and varus 
alignment medial progression. The presence of intra-articular damage in the history 
of the knee, ranging from isolated meniscal tear to anterior cruciate ligament rupture 
to major intra-articular knee injuries, contributes to the odds of developing knee OA 
too.7  
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Resurfacing the knee joint with a TKR is the final step in the treatment of OA of the 
knee. First, conservative (i.e. non-operative) treatment (like stepped care treatment) 
should be used exhaustively.8,9  
Disease modifying OA drugs (DMOADs) 
Oral diacerein, an IL-1β inhibitor, showed significant improvement of symptoms in 
patients with knee or hip OA.10 Also an agent like chondroitin sulphate has proved to 
have DMOAD potential. Several placebo controlled trials showed more radiographic 
joint space narrowing in placebo users compared to chondroitin sulphate users.11,12 
Tetracycline analogues, like doxycycline, inhibit some MMPs. A placebo controlled 
study showed less joint space narrowing in patients who received doxycycline versus 
placebo.13 However it seems that the symptomatic benefit of doxycycline is minimal, 
while the small benefit in terms of reduction of joint space narrowing is of 
questionable clinical relevance and outweighed by safety issues.14 Other agents, like 
(oral) bisphosphonates, calcitonin (i.e. second generation calcitonin peptides), 
strontium, cathepsin K inhibitors, and sprifermin are promising and are currently 
under investigation in different phases of trials.15 
Clinical relevant OA 
Patients’ main complaint when seeking clinical help for knee OA is pain. 
Radiographic OA is only weakly associated with pain.16 This suggests that other 
features, such as biochemical, cellular or structural changes, but also pain 
sensitization are important factors in pain perception.17 Although the link between 
radiological OA and pain is weak, some authors show an association between pain 
and structural, subchondral bone changes.18 Other studies, using contrast enhanced 
MRI, suggest an association between synovitis and pain.19-21 The cause of synovitis 
is not fully understood.17 A connection with nerve growth factor (NGF) has been 
proposed in the literature.22 NGF is identified to mediate in inflammatory joint pain 
and NGF blocking agents showed pain reduction in patient with knee OA.22 Research 
in this direction can add pain reducing agents to the traditional acetaminophen, 





Total knee replacement; expectations and satisfaction 
Patient satisfaction after TKR is important since its goals is to improve quality of life.23 
In Sweden 17% of over 25.000 patients after primary TKR were dissatisfied or 
uncertain on their outcome after TKR. Comparable results were found by our group 
in two cohort studies.24-26 This Swedish study showed also that satisfaction was 
related to the chronicity of the disease; those who suffered longer (e.g. in rheumatoid 
arthritis) were more satisfied after TKR than those who suffered from knee OA of 
more recent onset.24 Also preoperative radiological OA was associated with 
postoperative satisfaction.25,26 The largest risk factor for dissatisfaction are unmet 
preoperative expectations (Risk Ratio, RR, of 10.8), which is even higher compared 
to a RR of 1.9 for postoperative complications requiring re-admission to the 
hospital.23 Furthermore satisfaction is most strongly associated with improvement of 
pain scores after TKR.27 Other studies showed that, despite not all expectations are 
fulfilled, patients seem to be good to reasonably satisfied after TKR.28,29  
Recently the ICHOM working group on hip and knee OA defined a ‘Standard Set’ of 
outcome measures intended for evaluating the treatment of hip and knee OA hereby 
facilitating international comparisons of treatment and benchmarking on outcome and 
patient values across health care systems.30 
Implications for the future 
An important part of research in the field of osteoarthritis the coming years will focus 
on the prevention of OA. The step by step revelation how OA develops and how pain 
originates from the joint or acts as a centrally modulated entity will be important. 
Postponing and possibly preventing TKR surgery by conservative treatment options 
is only feasible if the patient has good functional results with high quality of life. 
Therapeutic intervention should focus on a combination of pain relief and functional 
improvement. With the end-goal in future to stop disease progression. For that 
matter, selective targeting IL-1β drugs are currently one of the most promising OA 
treatment strategies but many other disease modifying and pain reducing agents are 
currently being investigated. 
Focus should shift away from fixing radiological OA to treating and counseling 






Resurfacing the knee joint with a TKR is the final step in the treatment of OA of the 
knee. First, conservative (i.e. non-operative) treatment (like stepped care treatment) 
should be used exhaustively.8,9  
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patients with knee or hip OA.10 Also an agent like chondroitin sulphate has proved to 
have DMOAD potential. Several placebo controlled trials showed more radiographic 
joint space narrowing in placebo users compared to chondroitin sulphate users.11,12 
Tetracycline analogues, like doxycycline, inhibit some MMPs. A placebo controlled 
study showed less joint space narrowing in patients who received doxycycline versus 
placebo.13 However it seems that the symptomatic benefit of doxycycline is minimal, 
while the small benefit in terms of reduction of joint space narrowing is of 
questionable clinical relevance and outweighed by safety issues.14 Other agents, like 
(oral) bisphosphonates, calcitonin (i.e. second generation calcitonin peptides), 
strontium, cathepsin K inhibitors, and sprifermin are promising and are currently 
under investigation in different phases of trials.15 
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sensitization are important factors in pain perception.17 Although the link between 
radiological OA and pain is weak, some authors show an association between pain 
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MRI, suggest an association between synovitis and pain.19-21 The cause of synovitis 
is not fully understood.17 A connection with nerve growth factor (NGF) has been 
proposed in the literature.22 NGF is identified to mediate in inflammatory joint pain 
and NGF blocking agents showed pain reduction in patient with knee OA.22 Research 
in this direction can add pain reducing agents to the traditional acetaminophen, 





Total knee replacement; expectations and satisfaction 
Patient satisfaction after TKR is important since its goals is to improve quality of life.23 
In Sweden 17% of over 25.000 patients after primary TKR were dissatisfied or 
uncertain on their outcome after TKR. Comparable results were found by our group 
in two cohort studies.24-26 This Swedish study showed also that satisfaction was 
related to the chronicity of the disease; those who suffered longer (e.g. in rheumatoid 
arthritis) were more satisfied after TKR than those who suffered from knee OA of 
more recent onset.24 Also preoperative radiological OA was associated with 
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preoperative expectations (Risk Ratio, RR, of 10.8), which is even higher compared 
to a RR of 1.9 for postoperative complications requiring re-admission to the 
hospital.23 Furthermore satisfaction is most strongly associated with improvement of 
pain scores after TKR.27 Other studies showed that, despite not all expectations are 
fulfilled, patients seem to be good to reasonably satisfied after TKR.28,29  
Recently the ICHOM working group on hip and knee OA defined a ‘Standard Set’ of 
outcome measures intended for evaluating the treatment of hip and knee OA hereby 
facilitating international comparisons of treatment and benchmarking on outcome and 
patient values across health care systems.30 
Implications for the future 
An important part of research in the field of osteoarthritis the coming years will focus 
on the prevention of OA. The step by step revelation how OA develops and how pain 
originates from the joint or acts as a centrally modulated entity will be important. 
Postponing and possibly preventing TKR surgery by conservative treatment options 
is only feasible if the patient has good functional results with high quality of life. 
Therapeutic intervention should focus on a combination of pain relief and functional 
improvement. With the end-goal in future to stop disease progression. For that 
matter, selective targeting IL-1β drugs are currently one of the most promising OA 
treatment strategies but many other disease modifying and pain reducing agents are 
currently being investigated. 
Focus should shift away from fixing radiological OA to treating and counseling 
patients. As part of the patient informed consent procedure on TKR surgery, 
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assessment of patients’ expectations is important. If a mismatch between  
expectations of patient and  orthopedic surgeon exists, TKR surgery should be 
postponed and expectations should be managed.  
A more uniform approach in the treatment of knee OA will benefit not only research, 
education and economic analyses in knee OA patients between centers and between 
countries, but will mainly benefit patient perceived and expected outcome. Tools as 
the ICHOM Standard Set or the OECD (organization for economic collaboration and 
development, www.OECD.org) should be used.30 
Overall, treatment of knee OA should be more holistic, which means taking the 
patient and not only the “knee” into account. The latter implies to take also lifestyle 
interventions, patient education, physical exercises, oral medication, intra-articular 
injections with steroid derivatives to TKR into account as possible treatment options.  
Part 2 – on intra-operative issues 
TKR is a rather successful treatment which is routinely performed by orthopedic 
surgeons worldwide. Several topics to improve TKR still remain under discussion. It 
has been suggested that topical application of a fibrin sealant (a locally applied 
hemostatic agent) could be beneficial in terms of reducing hemoglobin loss or the 
frequency of red blood cell transfusions. In chapter 6 results of a large multi-center 
randomized controlled trial are reported. With current restrictive transfusion protocols, 
transfusion rates have diminished and are not as important an outcome as before. 
However it is suggested that after TKR surgery still 650-700 mL blood loss occurs. 
This volume of blood in the knee can impair postoperative function. In our study 
primary outcome was knee extension after TKR, this did not differ when fibrin sealant 
was applied during surgery. Also, when taking into account the use of vacuum 
drainage no difference in knee extension (or other functional outcomes) was 
identified.  
An ongoing discussion in TKR is whether or not to sacrifice the posterior cruciate 
ligament (PCL). Chapter 7 describes the results from a large systematic review and 
meta-analysis conducted within the Cochrane framework and published both in a 
journal and in the Cochrane library for systematic reviews. Because 2.347 knees 




of PCL resection, of 2.1 degrees was statistically significant. This difference is 
clinically not relevant. So it can be concluded that no functional, clinical or 
radiological differences were found between TKR with or without PCL sacrifice.  
After primary TKR or THR a prosthetic joint infection could develop. Hypothermia 
could raise the risk of infection. Heating the patient by forced-air can disrupt laminar 
airflow at the operation room (OR), potentially raising the risk of infection. In chapter 
8 we aimed to study the occurrence of hypothermia in patients who received active 
heating or forced-air heating. In this study both warming blankets did not prevent 
hypothermia during the surgery.  Although a difference of 0.2 oC was found between 
both groups at the end of TKR/THR surgery, we consider this difference not clinically 
relevant. The complication rate in both groups was the same. 
Surgical issues to consider 
In TKR surgery several issues can be considered, all of them having (strong) 
advocates and opponents. One of these issues is implant design. Besides the issue 
of retention or sacrifice the posterior cruciate ligament (as discussed in Chapter 7 of 
this thesis) another point of debate is the use of a fixed or mobile bearing for the tibial 
baseplate. Some authors report superior results of one of these bearings, however 
systematic reviews report no significant differences on a wide range of outcomes for 
either one of these bearings.31-33 
A TKR can be placed either in a measured resection (i.e. bony referenced) or 
ligament balanced fashion. In both techniques the goal is to match flexion and 
extension gaps in order to produce a stable and mobile TKR, without resecting too 
much bone and without altering the joint line to a too great extent.34,35 In a systematic 
review and meta-analysis comparing both techniques clinical outcomes were 
reported to be similar, ligament balanced TKR showed slightly more femoral 
component external rotation and joint line elevation than measured resected TKRs.36 
TKR can be placed using computer navigation. During the past twenty years 
computer navigation has improved (less outliers in alignment or component 
positioning), became less expensive, faster, but has failed to show improvement in 
patient reported outcomes in terms of functionality or satisfaction.37-39 It should be 
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either one of these bearings.31-33 
A TKR can be placed either in a measured resection (i.e. bony referenced) or 
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much bone and without altering the joint line to a too great extent.34,35 In a systematic 
review and meta-analysis comparing both techniques clinical outcomes were 
reported to be similar, ligament balanced TKR showed slightly more femoral 
component external rotation and joint line elevation than measured resected TKRs.36 
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computer navigation has improved (less outliers in alignment or component 
positioning), became less expensive, faster, but has failed to show improvement in 
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related techniques is important.40 Radiostereometric analysis might aid in this 
process, since it detects within two years whether the implant has good implant-bone 
fixation, a proxy for late loosening if continuous migration is present.41 In line with 
developments in computer assisted TKR, robotic-assisted TKR is developed. Several 
systems are on the market with names as Robodoc, Navio, iBlock, MAKO and 
PiGalileo. Results are promising, safety has improved greatly, yet the use of robotics 
is still expensive and its benefits have to be proven in studies.42,43 
The development of three-dimensional printing technology has enabled the 
development of patient-specific cutting blocks. Studies show no improvement in 
clinical and functional outcomes when patient specific instrumentation is used.44,45 
The cutting block might be of use when extra-articular deformities are present, or 
when conventional placement is not possible (e.g. presence of osteosynthesis 
materials or an intramedullary tumor).46 
The frequency of red blood cell transfusions after TKR has significantly been 
decreased recent years.47 This is due to a more evidence based restrictive rationale 
on patient blood management. The use of tranexamic acid, intravenously, peri-
operatively, significantly reduces blood loss. Because of the low price of tranexamic 
acid this intervention is highly cost-effective.48,49 Evidence suggest that the either 
intravenous registration or the topical application of tranexamic acid in TKR surgery 
yield similar results.50   
Using a pneumatic tourniquet and its timing of release during TKR surgery remains a 
topic of debate. A tourniquet is said to reduce blood loss, facilitate optimal 
cementation and yield better visualization of the surgical field. However, 
neuromuscular injuries can occur, as well as postoperative pain, delayed wound 
healing and increased thrombotic events.51,52 Several systematic reviews on the 
timing of tourniquet release show reduced incidence of wound complications in early 
tourniquet release compared to late release, no other evident differences are 
seen.52,53  
Peri-operative pain management traditionally consisted of oral medication 
(acetaminophen, NSAIDs and/or opioids) in combination with spinal and/or epidural 




modalities have multiple side-effects delaying rehabilitation after TKR surgery.54,55 
Local infiltrative analgesia (LIA) during the TKR surgery is proved to be beneficial in 
both reducing pain and preventing the aforementioned side-effects.56 Several 
‘cocktails’ are described, all containing ropivacaine and epinephrine. The solution is 
injected during several moments of the surgery, within the posterior capsule, the 
anterior capsule and the subcutaneous layer.55  
About two decades ago, first in the USA (Florida), later on in Denmark, the idea of 
fast track TKR started to spread across parts of the world.57 The program consists of 
patient education, the peroperative use of local infiltrative anesthesia (LIA) instead of 
postoperative opioids, no drains, standardized physiotherapy and the use of a skilled 
and dedicated surgical and rehabilitation team. This ultimately can result in daycare 
surgery for TKR in selected patients.57-59 A recent study from Denmark showed that 
15% of unselected TKR and total hip replacement patients can be discharged at the 
day of surgery.60 Although some studies report some a relapse of functional deficit 
once the patient is home in his or hers own social environment. 
Analyzing and evaluating the outcome after TKR and all related issues can be done 
by clinical studies with respect to functional, clinical and/or radiological outcomes. On 
the other hand revision rates, infection rates, implant survival can be studied better 
using data from implant registries.61,62 Including PROMS in registry data might yield 
better understanding of (patient) factors that contribute to pain relief, functional 
improvement and patient satisfaction.63 There is some experience abroad.64,65 It is 
worth mentioning that valuable correlations can be identified using registry data, 
however confounding should be considered when analyzing these kind of datasets.66 
An international working group published recommendations for choice of PROMS, 
survey logistics, timing, reporting missing values and analysis of data.67  
 
Implications for the future 
Some technical issues in TKR surgery could be left to the surgeons’ preference; 
whether to sacrifice the posterior cruciate ligament or not, whether to use a fixed or 
mobile bearing implant and whether to use a measured resection or ligament 
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Implications for the future 
Some technical issues in TKR surgery could be left to the surgeons’ preference; 
whether to sacrifice the posterior cruciate ligament or not, whether to use a fixed or 
mobile bearing implant and whether to use a measured resection or ligament 
balanced technique since the surgical technique itself is individualized not only to the 
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patient but also for a specific surgeon. Orthopedic surgeons should think about the 
use of a pneumatic tourniquet (preferably not to use a tourniquet) and if still used the 
timing of release is important. Tranexamic acid should routinely be used 
perioperatively as well as local infiltrative analgesia (LIA) during surgery if not 
contraindicated otherwise.  
Patient specific instrumentation could have a place in the future when used for strict 
indications (e.g. extra-articular deformities, intramedullary tumors), but not for routine 
use. Robotic assisted TKR might have a place in the future of TKR.  
Patients should remain within the hospital as long as appropriate. Outpatient TKR on 
selected on unselected patients should be further evaluated. Both in terms of safety 
aspects and potential economic benefits.  
PROMs need to be recorded in the Dutch registry LROI in order to understand and 
interpret registry data, but mainly as a quality control tool to monitor performance of 
the surgical procedure, indication for surgery and outcome. Preferably these data 
should be benchmarked with colleagues in order to improve outcome for patients. 
The Dutch Orthopedic Association (NOV), using national registry data (LROI data), 
has developed a protocol on how to deal with outlier clinical practices (i.e. 1% highest 
revision rate practices) since 2017. Since TKR is only one small step in the clinical 
pathway of OA treatment of the lower extremity, which is indicated by data showing 
that within one year after TKR/THR surgery, about 20% of patients will have severe 
clinical symptoms of the contralateral knee or hip or ipsilateral hip and are in need for 
a total joint replacement.68 Thus, a more holistic approach towards OA as a disease 
and not as a single joint problem is necessary. For that matter the orthopedic 
surgeon should have expertise on etiology and conservative treatment modalities in 
order to recommend optimal management, which can be both pharmacological as 
well as surgical or using physiotherapy. Only then shared decision making between 
patient and orthopedist (i.e. who is both surgeon as well as expert in conservative 
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Dutch summary /  Nederlandse samenvatting 
  




Het aantal Totale Knie Protheses (TKP’s) dat per jaar wereldwijd geplaatst wordt 
groeit nog altijd. De TKP wordt gezien als het eindstadium in de behandeling van 
gonartrose; artrose van de knie. Van oudsher worden prestaties van orthopedische 
implantaten gemeten in overlevingsstatistieken. Het doel hiervan is om te zien hoe 
lang het duurt voordat de TKP gereviseerd moet worden. De overleving van TKP’s is 
in het algemeen goed, daarom is er de laatste jaren steeds meer aandacht voor 
patiënt gerelateerde uitkomsten zoals patiënttevredenheid of kwaliteit van leven na 
de operatie. In hoofdstuk 2 wordt een studie beschreven naar de 
patiënttevredenheid en de kwaliteit van leven lange tijd na een TKP of totale heup 
prothese (THP) operatie; dat wil zeggen meer dan tien jaar na deze operatie. Hieruit 
blijkt dat zowel patiënten na TKP als na THP zeer tevreden zijn en hoge kwaliteit van 
leven scores laten zien. Het lijkt er echter ook op dat de mensen na een 
heupprothese iets meer tevreden zijn dan na een knieprothese.  
De indicatiestelling (het selecteren van de juiste patiënten voor de behandeling) voor 
het overgaan tot het plaatsen van een TKP is in het algemeen belangrijk, maar zou 
ook een rol hebben kunnen spelen bij het eerder genoemde verschil in tevredenheid. 
Op dit moment bestaan er geen harde richtlijnen wanneer een TKP te plaatsen. Om 
een idee te krijgen wanneer in de praktijk in Nederland een orthopedisch chirurg 
overgaat tot het plaatsen van een TKP werd een onderzoek gedaan onder alle 
Nederlandse orthopedisch chirurgen. Zij kregen drie casus beschrijvingen 
toegestuurd met de vraag of ze een TKP zouden plaatsen of niet. De casus waren 
helemaal identiek op één onderdeel na en de orthopedisch chirurgen kregen 
willekeurig één van de twee versies voor zich (hoofdstuk 3). Het lijkt erop dat in de 
praktijk de graad van radiologische artrose en het hebben van oudere leeftijd 
belangrijke factoren waren om over te gaan tot het aanbevelen van een TKP. De 
mate van pijn leek minder belangrijk bij het stellen van de indicatie, hoewel uit de 
literatuur voortkomt dat het hebben van voldoende pijn de belangrijkste indicatie zou 
moeten zijn. In hoofdstuk 4 wordt vervolgens de indicatiestelling voor TKP 
vergeleken tussen Nederlandse orthopedisch chirurgen met die uit verschillende 




negen landen lijkt het erop dat Nederlandse orthopedisch chirurgen het meest 
terughoudend zijn in het aanbevelen van een TKP. Uit ditzelfde onderzoek blijkt dat 
Nederlandse patiënten ten tijde van de indicatiestelling de hoogste kwaliteit van 
leven scores hadden. 
In hoofdstuk 5 worden uitkomsten van de Leiden 85+ studie besproken. Het gaat 
hier om uitkomsten op het gebied van functionele prestaties van de oudste ouderen, 
namelijk die van 85 jaar en ouder, met TKP of THP en die prestaties bij oudste 
ouderen zonder een dergelijke prothese. De oudste ouderen met prothese 
presteerden functioneel net zo goed als de oudste ouderen zonder prothese. Ook het 
gezondheidsniveau was vergelijkbaar tussen de twee groepen.  
TKP wordt gezien als een succesvolle behandeling van gonartrose en wordt 
wereldwijd door vele orthopedisch chirurgen ingezet. Er blijven rondom de TKP 
behandeling een aantal zaken punt van discussie. Zo wordt er gesteld dat het  
aanbrengen van een fibrinelijm in de knie tijdens de operatie een gunstig effect zou 
hebben op het hemoglobine verlies of op het aantal bloedtransfusies rondom de 
operatie. In hoofdstuk 6 worden de resultaten beschreven van een grote 
gerandomiseerde klinische studie in meerder ziekenhuizen naar het effect van een 
fibrinelijm bij TKP operaties. De huidige zorgpaden bij TKP zijn zeer terughoudend 
met het toedienen van bloedtransfusies en het routinematig controleren van 
hemoglobine gehalte in het bloed. Vandaar dat in de studie met fibrinelijm gekozen is 
voor een functionele uitkomstmaat, namelijk de extensie (‘het strekken’) van de knie. 
Uit eerder onderzoek weten we dat er na TKP operaties zo’n 650-700 mL 
bloedverlies is wat onder andere in de knie kan blijven en kan zorgen voor een 
extensiebeperking (strekbeperking) van de knie met als gevolg een mogelijk 
moeizamere revalidatie van de operatie. Er werd geen verschil gevonden in knie 
extensie tussen patiënten die met of zonder fibrinelijm geopereerd waren. Ook 
wanneer het gebruik van drains meegenomen werd in de analyse werd er geen 
verschil gevonden.  
Een andere voortdurende discussie onder kniechirurgen is het al dan niet offeren van 
de achterste kruisband. Hoofdstuk 7 rapporteert de resultaten van een 
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negen landen lijkt het erop dat Nederlandse orthopedisch chirurgen het meest 
terughoudend zijn in het aanbevelen van een TKP. Uit ditzelfde onderzoek blijkt dat 
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leven scores hadden. 
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presteerden functioneel net zo goed als de oudste ouderen zonder prothese. Ook het 
gezondheidsniveau was vergelijkbaar tussen de twee groepen.  
TKP wordt gezien als een succesvolle behandeling van gonartrose en wordt 
wereldwijd door vele orthopedisch chirurgen ingezet. Er blijven rondom de TKP 
behandeling een aantal zaken punt van discussie. Zo wordt er gesteld dat het  
aanbrengen van een fibrinelijm in de knie tijdens de operatie een gunstig effect zou 
hebben op het hemoglobine verlies of op het aantal bloedtransfusies rondom de 
operatie. In hoofdstuk 6 worden de resultaten beschreven van een grote 
gerandomiseerde klinische studie in meerder ziekenhuizen naar het effect van een 
fibrinelijm bij TKP operaties. De huidige zorgpaden bij TKP zijn zeer terughoudend 
met het toedienen van bloedtransfusies en het routinematig controleren van 
hemoglobine gehalte in het bloed. Vandaar dat in de studie met fibrinelijm gekozen is 
voor een functionele uitkomstmaat, namelijk de extensie (‘het strekken’) van de knie. 
Uit eerder onderzoek weten we dat er na TKP operaties zo’n 650-700 mL 
bloedverlies is wat onder andere in de knie kan blijven en kan zorgen voor een 
extensiebeperking (strekbeperking) van de knie met als gevolg een mogelijk 
moeizamere revalidatie van de operatie. Er werd geen verschil gevonden in knie 
extensie tussen patiënten die met of zonder fibrinelijm geopereerd waren. Ook 
wanneer het gebruik van drains meegenomen werd in de analyse werd er geen 
verschil gevonden.  
Een andere voortdurende discussie onder kniechirurgen is het al dan niet offeren van 
de achterste kruisband. Hoofdstuk 7 rapporteert de resultaten van een 
systematische review en meta-analyse binnen het kader van Cochrane waarvan de 
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resultaten zowel als artikel in de Acta Orthopaedica zijn gepubliceerd als in de 
Cochrane Library for Systematic Reviews. Er konden 2.347 knieën geanalyseerd 
worden in de meta-analyse waardoor er uitkwam dat TKP’s waarbij de achterste 
kruisband geofferd was 2.1 graden meer konden buigen. Dit was statistisch 
significant maar klinisch niet relevant. Uit dit onderzoek kan geconcludeerd worden 
dat er geen functionele, klinische of radiologische verschillen gevonden werden 
tussen TKP met of zonder opofferen van de achterste kruisband.  
Na TKP of THP kan een prothese infectie ontstaan. Dit is één van de meest 
gevreesde complicaties van de behandeling en er wordt veel moeite gedaan om het 
risico op een infectie tot een minimum te beperken. Hypothermie (waarbij de 
temperatuur van patiënten tussen de 34 en 36 oC is) kan ontstaan tijdens de operatie 
en kan het risico op infectie doen toenemen. Hierom worden patiënten tijdens de 
operatie verwarmd. De meest gebruikte deken hiervoor maakt gebruikt van warme 
lucht. Deze warme lucht kan de luchtstroom op de operatiekamer dusdanig verstoren 
dat het risico op infectie van het operatiegebied weer toeneemt. In hoofdstuk 8 
beschrijven we een onderzoek waarbij we onderzocht hebben of de warme lucht 
deken en een deken die uit zichzelf warm is en daarbij de luchtstroom niet verstoord 
beiden in staat zijn om hypothermie te voorkomen. Met het idee dat wanneer de 
deken die de luchtstroom niet verstoord even effectief is als de ander dat deze 
wellicht de voorkeur zou moeten genieten. We vonden een verschil van 0.2 oC ten 
nadele van de deken die zelf verwarmd. Dit verschil beschouwen we als niet 
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